2023
Hedrich, C. M., Beresford, M. W., Dedeoglu, F., Hahn, G., Hofmann, S. R., Jansson, A. F., . . . Girschick, H. J. (2023). Gathering expert consensus to inform a proposed trial in chronic nonbacterial osteomyelitis (CNO).. Clinical immunology (Orlando, Fla.), 251, 109344. doi:10.1016/j.clim.2023.109344DOI: 10.1016/j.clim.2023.109344
Smith, E. M. D., Aggarwal, A., Ainsworth, J., Al-Abadi, E., Avcin, T., Bortey, L., . . . Beresford, M. W. (2023). Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force. ANNALS OF THE RHEUMATIC DISEASES. doi:10.1136/ard-2022-223328DOI: 10.1136/ard-2022-223328
Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Douglas, S., Foster, H. E., Southwood, T. R., . . . Ciurtin, C. (2023). Successful stopping of biologic therapy for remission in children and young people with juvenile idiopathic arthritis. RHEUMATOLOGY, 62(5), 1926-1935. doi:10.1093/rheumatology/keac463DOI: 10.1093/rheumatology/keac463
PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS) (Journal article)
Smith, E. M. D., Aggarwal, A., Ainsworth, J., Al-Abadi, E., Avcin, T., Bortey, L., . . . Beresford, M. W. (2023). PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS). CLINICAL IMMUNOLOGY, 250. doi:10.1016/j.clim.2023.109296DOI: 10.1016/j.clim.2023.109296
Wright, R. D., Marro, J., Northey, S. J., Corkhill, R., Beresford, M. W., & Oni, L. (2023). Urinary complement proteins are increased in children with IgA vasculitis (Henoch-Schonlein purpura) nephritis. PEDIATRIC NEPHROLOGY, 38(5), 1491-1498. doi:10.1007/s00467-022-05747-3DOI: 10.1007/s00467-022-05747-3
Pulmonary hypertension in juvenile-onset systemic lupus erythematosus: a case series. (Journal article)
Platt, C., Longthorpe, C., Sit, J., Marks, S. D., Harmer, M., Ciurtin, C., . . . UK JSLE Study Group. (2023). Pulmonary hypertension in juvenile-onset systemic lupus erythematosus: a case series.. Clinical and experimental rheumatology. doi:10.55563/clinexprheumatol/pye2t3DOI: 10.55563/clinexprheumatol/pye2t3
Letter to the editor re article "The Climate Emergency and the Health of Our Patients: The Role of the Rheumatologist" January 2023. (Journal article)
Hospach, T., Belot, A., Beresford, M. W., Dressler, F., Kallinich, T., Oommen, P., . . . Hedrich, C. M. (2023). Letter to the editor re article "The Climate Emergency and the Health of Our Patients: The Role of the Rheumatologist" January 2023.. Arthritis & rheumatology (Hoboken, N.J.). doi:10.1002/art.42483DOI: 10.1002/art.42483
Charras, A., Haldenby, S., Smith, E. M. D., Egbivwie, N., Olohan, L., Kenny, J. G., . . . Hedrich, C. M. (2023). Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE. RHEUMATOLOGY, 62(SI2), SI210-SI225. doi:10.1093/rheumatology/keac275DOI: 10.1093/rheumatology/keac275
Gavan, S. P., Bruce, I. N., Payne, K., & MASTERPLANS Consortium. (2023). Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 26(1), 115-122. doi:10.1016/j.jval.2022.07.001DOI: 10.1016/j.jval.2022.07.001
2022
Smith, E. M. D., Tharmaratnam, K., Al-Abadi, E., Armon, K., Bailey, K., Brennan, M., . . . Beresford, M. W. (n.d.). Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus. Rheumatology. doi:10.1093/rheumatology/keab915DOI: 10.1093/rheumatology/keab915
Smith, E. M. D., Egbivwie, N., Jorgensen, A. L., Ciurtin, C., Al-Abadi, E., Armon, K., . . . Hedrich, C. M. (2022). Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort study. CLINICAL IMMUNOLOGY, 239. doi:10.1016/j.clim.2022.109028DOI: 10.1016/j.clim.2022.109028
Gallagher, K. L., Patel, P., Beresford, M. W., & Smith, E. M. D. (2022). What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012?. FRONTIERS IN PEDIATRICS, 10. doi:10.3389/fped.2022.884634DOI: 10.3389/fped.2022.884634
Stuck in transit: A qualitative study of the transitional care needs of young people with epilepsy and juvenile idiopathic arthritis (Journal article)
Wilson, N., Whittaker, K., Arnott, J., Burke, L., Beresford, M. W., & Peak, M. (2022). Stuck in transit: A qualitative study of the transitional care needs of young people with epilepsy and juvenile idiopathic arthritis. JOURNAL OF CHILD HEALTH CARE. doi:10.1177/13674935221074777DOI: 10.1177/13674935221074777
Carlsson, E., Quist, A., Davies, J. C., Midgley, A., Smith, E. M. D., Bruce, I. N., . . . Hedrich, C. M. (2022). Longitudinal analysis of urinary proteins in lupus nephritis – A pilot study. Clinical Immunology, 236, 108948. doi:10.1016/j.clim.2022.108948DOI: 10.1016/j.clim.2022.108948
Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of Ireland (Journal article)
Lythgoe, H., Smith, E. M. D., Killeen, O. G., Murphy, R., Pilkington, C., Pain, C. E., & Beresford, M. W. (2022). Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of Ireland. RHEUMATOLOGY. doi:10.1093/rheumatology/keac064DOI: 10.1093/rheumatology/keac064
2021
Comment on: Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?: Reply (Journal article)
Smith, E. M. D., Beresford, M. W., McCann, L., & Hedrich, C. M. (2022). Comment on: Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?: Reply. RHEUMATOLOGY, 61(1), E27-E28. doi:10.1093/rheumatology/keab667DOI: 10.1093/rheumatology/keab667
Rodsaward, P., Chottawornsak, N., Suwanchote, S., Rachayon, M., Deekajorndech, T., Wright, H. L., . . . Chiewchengchol, D. (2021). The clinical significance of antinuclear antibodies and specific autoantibodies in juvenile and adult systemic lupus erythematosus patients. ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 39(4), 279-286. doi:10.12932/AP-211218-0465DOI: 10.12932/AP-211218-0465
Smith, E. M. D., Gorst, S. L., Al-Abadi, E., Hawley, D. P., Leone, V., Pilkington, C., . . . Young, B. (n.d.). “It is good to have a target in mind”: Qualitative views of patients and parents informing a treat to target clinical trial in JSLE. Rheumatology. doi:10.1093/rheumatology/keab173DOI: 10.1093/rheumatology/keab173
Giani, T., Smith, E. M., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., . . . Hedrich, C. M. (2021). Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study. LUPUS, 30(12), 1955-1965. doi:10.1177/09612033211045050DOI: 10.1177/09612033211045050
Zaripova, L. N., Midgley, A., Christmas, S. E., Beresford, M. W., Baildam, E. M., & Oldershaw, R. A. (2021). Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. PEDIATRIC RHEUMATOLOGY, 19(1). doi:10.1186/s12969-021-00629-8DOI: 10.1186/s12969-021-00629-8
Carlsson, E., Midgley, A., Perkins, S., Caamano-Gutierrez, E., Gritzfeld, J. F., Beresford, M. W., & Hedrich, C. M. (2021). Serum protein signatures differentiate paediatric autoimmune/ inflammatory disorders. CLINICAL IMMUNOLOGY, 229. doi:10.1016/j.clim.2021.108790DOI: 10.1016/j.clim.2021.108790
Carlsson, E., Beresford, M. W., Ramanan, A. V., Dick, A. D., & Hedrich, C. M. (2021). Juvenile Idiopathic Arthritis Associated Uveitis. CHILDREN-BASEL, 8(8). doi:10.3390/children8080646DOI: 10.3390/children8080646
Oni, L., Wright, R. D., Marks, S., Beresford, M. W., & Tullus, K. (2021). Kidney outcomes for children with lupus nephritis. PEDIATRIC NEPHROLOGY, 36(6), 1377-1385. doi:10.1007/s00467-020-04686-1DOI: 10.1007/s00467-020-04686-1
REAL-WORLD EFFECTIVENESS OF ETANERCEPT AND ADALIMUMAB IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA) WITHOUT UVEITIS (Conference Paper)
Kearsley-Fleet, L., Baildam, E., Beresford, M., Foster, H., Southwood, T., Thomson, W., & Hyrich, K. (2021). REAL-WORLD EFFECTIVENESS OF ETANERCEPT AND ADALIMUMAB IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA) WITHOUT UVEITIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 80 (pp. 927). doi:10.1136/annrheumdis-2021-eular.186DOI: 10.1136/annrheumdis-2021-eular.186
Massias, J. S., Smith, E. M. D., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., . . . Hedrich, C. M. (2021). Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK. LUPUS, 30(4), 597-607. doi:10.1177/0961203320984251DOI: 10.1177/0961203320984251
Brogan, P. A., Arch, B., Hickey, H., Anton, J., Iglesias, E., Baildam, E., . . . Eleftheriou, D. (2021). Mycophenolate mofetil versus cyclophosphamide for remission induction in childhood polyarteritis nodosa: An open label, randomised, Bayesian, non-inferiority trial.. Arthritis & rheumatology (Hoboken, N.J.). doi:10.1002/art.41730DOI: 10.1002/art.41730
Smith, E. M. D., Rasul, S., Ciurtin, C., Al-Abadi, E., Armon, K., Bailey, K., . . . Hedrich, C. M. (2021). Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study. RHEUMATOLOGY, 60(11), 5271-5281. doi:10.1093/rheumatology/keab210DOI: 10.1093/rheumatology/keab210
Taylor-Robinson, D. (2021). Behçet’s syndrome in children and young people in the United Kingdom &Republic of Ireland: a prospective epidemiological study. Rheumatology. doi:10.1093/rheumatology/keab084DOI: 10.1093/rheumatology/keab084
Shoop-Worrall, S. J. W., Hyrich, K. L., Wedderburn, L. R., Thomson, W., Geifman, N., Baildam, E., . . . Yarwood, A. (2021). Patient-reported wellbeing and clinical disease measures over time captured by multivariate trajectories of disease activity in individuals with juvenile idiopathic arthritis in the UK: a multicentre prospective longitudinal study. The Lancet Rheumatology, 3(2), e111-e121. doi:10.1016/s2665-9913(20)30269-1DOI: 10.1016/s2665-9913(20)30269-1
2020
Davies, J., Carlsson, E., Midgley, A., Smith, E., Bruce, I., Beresford, M., & Hedrich, C. (2020). A Panel of Urinary Proteins Predicts Active Lupus Nephritis and Response to Rituximab Treatment. ARTHRITIS & RHEUMATOLOGY, 72. Retrieved from http://gateway.webofknowledge.com/
Smith, E. M. D., Ainsworth, S., Beresford, M. W., Buys, V., Costello, W., Egert, Y., . . . Stones, S. R. (2020). Establishing an international awareness day for paediatric rheumatic diseases: reflections from the inaugural World Young Rheumatic Diseases (WORD) Day 2019. PEDIATRIC RHEUMATOLOGY, 18(1). doi:10.1186/s12969-020-00465-2DOI: 10.1186/s12969-020-00465-2
Davies, J. C., Midgley, A., Carlsson, E., Donohue, S., Bruce, I. N., Beresford, M. W., & Hedrich, C. M. (2020). Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment. RMD OPEN, 6(2). doi:10.1136/rmdopen-2020-001257DOI: 10.1136/rmdopen-2020-001257
Wright, R. D., Bannerman, F., Beresford, M. W., & Oni, L. (2020). A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy. BMC Nephrology, 21. doi:10.1186/s12882-020-01888-5DOI: 10.1186/s12882-020-01888-5
Davies, R., De Cock, D., Kearsley-Fleet, L., Southwood, T., Baildam, E., Beresford, M. W., . . . Hyrich, K. L. (2020). The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data. RHEUMATOLOGY, 59(6), 1391-1397. doi:10.1093/rheumatology/kez449DOI: 10.1093/rheumatology/kez449
Davies, J., Midgley, A., Donohue, S., Bruce, I. N., Beresford, M., & Hedrich, C. (2020). URINE AND SERUM S100 PROTEINS ASSOCIATE WITH LUPUS NEPHRITIS AND RESPONSE TO TREATMENT. In ANNALS OF THE RHEUMATIC DISEASES Vol. 79 (pp. 348). doi:10.1136/annrheumdis-2020-eular.1180DOI: 10.1136/annrheumdis-2020-eular.1180
Massias, J., Smith, E., Beresford, M., & Hedrich, C. (2020). Clinical and Laboratory Characteristics in Juvenile-onset Systemic Lupus Erythematosus Across Age Groups. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 95-96). Retrieved from https://www.webofscience.com/
Donohue, S., Midgley, A., Davies, J., Wright, R., Bruce, I., Beresford, M., & Hedrich, C. (2020). Differential Analysis of Serum and Urine S100 Proteins in Juvenile-onset Systemic Lupus Erythematosus (jSLE). In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 96-97). Retrieved from https://www.webofscience.com/
Donohue, S. J., Midgley, A., Davies, J. C., Wright, R. D., Bruce, I., Beresford, M. W., & Hedrich, C. M. (2020). Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE). CLINICAL IMMUNOLOGY, 214. doi:10.1016/j.clim.2020.108375DOI: 10.1016/j.clim.2020.108375
Massias, J. S., Smith, E. M. D., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., . . . Hedrich, C. M. (2020). Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. LUPUS, 29(5), 474-481. doi:10.1177/0961203320909156DOI: 10.1177/0961203320909156
de Graeff, N., Groot, N., Brogan, P., Ozen, S., Avcin, T., Bader-Meunier, B., . . . Beresford, M. W. (2020). European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative (vol 58, pg 656, 2019). RHEUMATOLOGY, 59(4), 919. doi:10.1093/rheumatology/keaa057DOI: 10.1093/rheumatology/keaa057
Kearsley-Fleet, L., Heaf, E., Davies, R., Baildam, E., Beresford, M. W., Foster, H. E., . . . BCRD and BSPAR-ETN study groups. (2020). Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study. The Lancet Rheumatology, 2(4), e217-e226. doi:10.1016/s2665-9913(20)30025-4DOI: 10.1016/s2665-9913(20)30025-4
Ramanan, A. V., Dick, A. D., Guly, C., McKay, A., Jones, A. P., Hardwick, B., . . . APTITUDE Trial Management Group. (2020). Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial. The Lancet Rheumatology, 2(3), e135-e141. doi:10.1016/s2665-9913(20)30008-4DOI: 10.1016/s2665-9913(20)30008-4
Belot, A., Rice, G. I., Omarjee, S. O., Rouchon, Q., Smith, E. M. D., Moreews, M., . . . Wood, F. (2020). Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts. The Lancet Rheumatology, 2(2), e99-e109. doi:10.1016/s2665-9913(19)30142-0DOI: 10.1016/s2665-9913(19)30142-0
Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study. (Journal article)
Jones, A. P., Clayton, D., Nkhoma, G., Sherratt, F. C., Peak, M., Stones, S. R., . . . Baildam, E. M. (2020). Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study.. Health Technology Assessment, 24(36), 1-152. doi:10.3310/hta24360DOI: 10.3310/hta24360
Giani, T., Smith, E., Cimaz, R., Beresford, M., & Hedrich, C. (2020). Neuropsychiatric Involvement in Juvenile-onset Systemic Lupus Erythematosus (JSLE): Data from the UK JSLE Cohort Study. In ARTHRITIS & RHEUMATOLOGY Vol. 72. Retrieved from https://www.webofscience.com/
2019
Smith, E. M. D., Lythgoe, H., Midgley, A., Beresford, M. W., & Hedrich, C. M. (2019). Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options. CLINICAL IMMUNOLOGY, 209. doi:10.1016/j.clim.2019.108274DOI: 10.1016/j.clim.2019.108274
cAMP Response Element Modulator α Induces Dual Specificity Protein Phosphatase 4 to Promote Effector T Cells in Juvenile-Onset Lupus (Journal article)
Hofmann, S. R., Mäbert, K., Kapplusch, F., Russ, S., Northey, S., Beresford, M. W., . . . Hedrich, C. M. (2019). cAMP Response Element Modulator α Induces Dual Specificity Protein Phosphatase 4 to Promote Effector T Cells in Juvenile-Onset Lupus. Journal of Immunology, 203(11), 2807-2816. doi:10.4049/jimmunol.1900760DOI: 10.4049/jimmunol.1900760
Wright, R. D., Dimou, P., Northey, S. J., & Beresford, M. W. (2019). Mesangial cells are key contributors to the fibrotic damage seen in the lupus nephritis glomerulus. JOURNAL OF INFLAMMATION-LONDON, 16(1). doi:10.1186/s12950-019-0227-xDOI: 10.1186/s12950-019-0227-x
Kearsley-Fleet, L., Adam, R., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2019). Biosimilar use in children and young people with juvenile idiopathic arthritis in a real-world setting in the United Kingdom. In RHEUMATOLOGY Vol. 58. Retrieved from https://www.webofscience.com/
Dolezalova, P., Anton, J., Avcin, T., Beresford, M. W., Brogan, P. A., Constantin, T., . . . Silvestri, G. (2019). The European network for care of children with paediatric rheumatic diseases: care across borders. RHEUMATOLOGY, 58(7), 1188-1195. doi:10.1093/rheumatology/key439DOI: 10.1093/rheumatology/key439
Rooney, M., Bishop, N., Davidson, J., Beresford, M. W., Pilkington, C., McDonagh, J., . . . Verghis, R. (2019). The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial. ECLINICALMEDICINE, 12, 79-87. doi:10.1016/j.eclinm.2019.06.004DOI: 10.1016/j.eclinm.2019.06.004
Horton, S., Jones, A. P., Guly, C. M., Hardwick, B., Beresford, M. W., Lee, R. W. J., . . . Ramanan, A. V. (2019). Adalimumab in juvenile-idiopathic arthritis-associated uveitis (JIA-U): 5-year follow-up of the Bristol participants of the SYCAMORE trial.. American journal of ophthalmology. doi:10.1016/j.ajo.2019.06.007DOI: 10.1016/j.ajo.2019.06.007
Dimou, P., Wright, R. D., Budge, K. L., Midgley, A., Satchell, S. C., Peak, M., & Beresford, M. W. (2019). The human glomerular endothelial cells are potent pro-inflammatory contributors in an in vitro model of lupus nephritis. SCIENTIFIC REPORTS, 9. doi:10.1038/s41598-019-44868-yDOI: 10.1038/s41598-019-44868-y
A NATIONAL SURVEY OF CLINICAL PRACTICE OF CORTICOSTEROID USE IN NEWLY DIAGNOSED OR FLARING CASES OF JUVENILE IDIOPATHIC ARTHRITIS ACROSS THE UK (Conference Paper)
Baildam, E., Jones, A., Clayton, D., Nkoma, G., Peak, M., Ramanan, A., . . . Beresford, M. (2019). A NATIONAL SURVEY OF CLINICAL PRACTICE OF CORTICOSTEROID USE IN NEWLY DIAGNOSED OR FLARING CASES OF JUVENILE IDIOPATHIC ARTHRITIS ACROSS THE UK. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 1934). doi:10.1136/annrheumdis-2019-eular.6751DOI: 10.1136/annrheumdis-2019-eular.6751
Lythgoe, H., Pain, C., Smith, E., & Beresford, M. (2019). DIAGNOSIS AND INITIAL MANAGEMENT OF JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS IN THE UK AND IRELAND. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 1329). doi:10.1136/annrheumdis-2019-eular.1587DOI: 10.1136/annrheumdis-2019-eular.1587
Ramanan, A. V., Hampson, L. V., Lythgoe, H., Jones, A. P., Hardwick, B., Hind, H., . . . Beresford, M. W. (2019). Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO. PLOS ONE, 14(6). doi:10.1371/journal.pone.0215739DOI: 10.1371/journal.pone.0215739
Beresford, M. (2019). HOT: MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS 2019 AND BEYOND. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 42). doi:10.1136/annrheumdis-2019-eular.8429DOI: 10.1136/annrheumdis-2019-eular.8429
IDENTIFYING THE PRIMARY OUTCOME MEASURE AND PROTOCOL COMPONENTS FOR A PROSPECTIVE FEASIBILITY STUDY OF CORTICOSTEROID REGIMENS FOR CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS USING CONSENSUS METHODS WITH YOUNG PEOPLE, FAMILIES AND PROFESSIONALS (Conference Paper)
Stones, S., Bagley, H., Jones, A., Mcerlane, F., Moitt, T., Nkhoma, G., . . . Baildam, E. (2019). IDENTIFYING THE PRIMARY OUTCOME MEASURE AND PROTOCOL COMPONENTS FOR A PROSPECTIVE FEASIBILITY STUDY OF CORTICOSTEROID REGIMENS FOR CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS USING CONSENSUS METHODS WITH YOUNG PEOPLE, FAMILIES AND PROFESSIONALS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 1934-1935). doi:10.1136/annrheumdis-2019-eular.1799DOI: 10.1136/annrheumdis-2019-eular.1799
Kearsley-Fleet, L., Davies, R., Page, J., Baildam, E., Beresford, M., Foster, H., . . . Hyrich, K. (2019). WHAT TO CHOOSE: A SECOND TNFI OR AN ALTERNATIVE CLASS OF BIOLOGIC FOR PATIENTS WITH JIA WHO HAVE FAILED THEIR FIRST TNFI. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 74-75). doi:10.1136/annrheumdis-2019-eular.415DOI: 10.1136/annrheumdis-2019-eular.415
Brunner, H. I., Holland, M. J., Beresford, M. W., Ardoin, S. P., Appenzeller, S., Silva, C. A., . . . Maldonado, I. (2019). American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus. ARTHRITIS CARE & RESEARCH, 71(5), 579-590. doi:10.1002/acr.23834DOI: 10.1002/acr.23834
Ramanan, A. V., Dick, A. D., Jones, A. P., Hughes, D. A., McKay, A., Rosala-Halas, A., . . . Grp, S. Y. C. A. M. O. R. E. S. (2019). Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT. HEALTH TECHNOLOGY ASSESSMENT, 23(15), 1-139. doi:10.3310/hta23150DOI: 10.3310/hta23150
Challenges of achieving clinical remission in a national cohort of juvenile-onset systemic lupus erythematosus patients (Journal article)
Abdelrahman, N., Beresford, M. W., & Leone, V. (2019). Challenges of achieving clinical remission in a national cohort of juvenile-onset systemic lupus erythematosus patients. LUPUS, 28(5), 667-674. doi:10.1177/0961203319840699DOI: 10.1177/0961203319840699
de Graeff, N., Groot, N., Ozen, S., Eleftheriou, D., Avcin, T., Bader-Meunier, B., . . . Beresford, M. W. (2019). European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative. RHEUMATOLOGY, 58(4), 672-682. doi:10.1093/rheumatology/key344DOI: 10.1093/rheumatology/key344
De Graeff, N., Groot, N., Brogan, P., Ozen, S., Avcin, T., Bader-Meunier, B., . . . Beresford, M. (2019). European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides – the SHARE initiative. Rheumatology, 58(4), 656-671. doi:10.1093/rheumatology/key322DOI: 10.1093/rheumatology/key322
Kearsley-Fleet, L., Heaf, E. D., Davies, R., De Cock, D., Baildam, E., Beresford, M. W., . . . Hyrich, K. L. (2019). HIGH SEQUENTIAL USE OF TUMOUR NECROSIS FACTOR INHIBITORS IN A COHORT OF CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS FROM THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 58 (pp. 32). Retrieved from https://www.webofscience.com/
Dawson, S. R., Linton, E., Beicher, K., Gale, R., Patel, P., Ghanchi, F., . . . Barry, R. (2019). Ophthalmology research in the UK's National Health Service: the structure and performance of the NIHR's Ophthalmology research portfolio. EYE, 33(4), 610-618. doi:10.1038/s41433-018-0251-8DOI: 10.1038/s41433-018-0251-8
Ozen, S., Marks, S. D., Brogan, P., Groot, N., de Graeff, N., Avcin, T., . . . Beresford, M. W. (2019). European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.. Rheumatology, 58(9), 1607-1616. doi:10.1093/rheumatology/kez041DOI: 10.1093/rheumatology/kez041
Smith, E., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., Davidson, J., . . . Hedrich, C. M. (2019). Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.. Lupus, 961203319836712. doi:10.1177/0961203319836712DOI: 10.1177/0961203319836712
Kearsley-Fleet, L., Gonzalez, L. V., Steinke, D., Davies, R., De Cock, D., Baildam, E., . . . Hyrich, K. L. (2019). Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis. RHEUMATOLOGY, 58(8), 1453-1458. doi:10.1093/rheumatology/kez048DOI: 10.1093/rheumatology/kez048
Hughes, D. A., Culeddu, G., Plumpton, C. O., Wood, E., Dick, A. D., Jones, A. P., . . . Ramanan, A. V. (2019). Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis. Ophthalmology, 126(3), 415-424. doi:10.1016/j.ophtha.2018.09.043DOI: 10.1016/j.ophtha.2018.09.043
Reply. (Journal article)
Hughes, D. A., Culeddu, G., Plumpton, C., Wood, E., Dick, A. D., Beresford, M. W., & Ramanan, A. V. (2019). Reply.. Ophthalmology, 126(3), e24-e25. doi:10.1016/j.ophtha.2018.12.005DOI: 10.1016/j.ophtha.2018.12.005
Attar, S. G., Poustie, V. J., Hawcutt, D. B., Oni, L., Beresford, M. W., & Pirmohamed, M. (2019). Working together to deliver stratified medicine research effectively. British Medical Bulletin. doi:10.1093/bmb/ldz003DOI: 10.1093/bmb/ldz003
Martini, A., Ravelli, A., Avcin, T., Beresford, M. W., Burgos-Vargas, R., Cuttica, R., . . . Ruperto, N. (2019). Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus. JOURNAL OF RHEUMATOLOGY, 46(2), 190-197. doi:10.3899/jrheum.180168DOI: 10.3899/jrheum.180168
Kearsley-Fleet, L., Sampath, S., McCann, L. J., Baildam, E., Beresford, M. W., Davies, R., . . . Hyrich, K. L. (2019). Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom. RHEUMATOLOGY, 58(2), 331-335. doi:10.1093/rheumatology/key306DOI: 10.1093/rheumatology/key306
Smith, E. M. D., Eleuteri, A., Goilav, B., Lewandowski, L., Phuti, A., Rubinstein, T., . . . Beresford, M. W. (2019). A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activity. CLINICAL IMMUNOLOGY, 198, 71-78. doi:10.1016/j.clim.2018.10.021DOI: 10.1016/j.clim.2018.10.021
A national survey of clinical practice of corticosteroid use in newly diagnosed or flaring cases of juvenile idiopathic arthritis across the UK (Conference Paper)
Jones, A., Clayton, D., Nkhoma, G., Sherratt, F., Peak, M., Ramanan, A., . . . Baildam, E. (2019). A national survey of clinical practice of corticosteroid use in newly diagnosed or flaring cases of juvenile idiopathic arthritis across the UK. In RHEUMATOLOGY Vol. 58 (pp. 7). Retrieved from https://www.webofscience.com/
Ding, W. Y., Beresford, M. W., Saleem, M. A., & Ramanan, A. V. (2019). Big data and stratified medicine: what does it mean for children?. ARCHIVES OF DISEASE IN CHILDHOOD, 104(4), 389-394. doi:10.1136/archdischild-2018-315125DOI: 10.1136/archdischild-2018-315125
Identifying the primary outcome measure and protocol components for a prospective feasibility study of corticosteroid regimens for CYP with JIA using consensus methods with young people, families and professionals (Conference Paper)
Stones, S. R., Bagley, H., Beresford, M. W., Jones, A., McErlane, F., Moitt, T., . . . Baildam, E. M. (2019). Identifying the primary outcome measure and protocol components for a prospective feasibility study of corticosteroid regimens for CYP with JIA using consensus methods with young people, families and professionals. In RHEUMATOLOGY Vol. 58. Retrieved from https://www.webofscience.com/
Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis REPLY (Journal article)
Hughes, D. A., Culeddu, G., Plumpton, C., Wood, E., Dick, A. D., Beresford, M. W., & Ramanan, A. V. (2019). Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis REPLY. OPHTHALMOLOGY, 126(3), E24-E25. doi:10.1016/j.ophtha.2018.12.005DOI: 10.1016/j.ophtha.2018.12.005
S100A8/A9 and S100A12 may be biomarkers for juvenile-onset systemic lupus erythematosus (Conference Paper)
Donohue, S. J., Midgley, A., Bruce, I., Beresford, M. W., & Hedrich, C. M. (2019). S100A8/A9 and S100A12 may be biomarkers for juvenile-onset systemic lupus erythematosus. In RHEUMATOLOGY Vol. 58. Retrieved from https://www.webofscience.com/
Kearsley-Fleet, L., Beresford, M. W., Davies, R., De Cock, D., Baildam, E., Foster, H. E., . . . Hyrich, K. L. (2019). Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra. RHEUMATOLOGY, 58(1), 94-102. doi:10.1093/rheumatology/key262DOI: 10.1093/rheumatology/key262
2018
Sherratt, F. C., Roper, L., Stones, S. R., McErlane, F., Peak, M., Beresford, M. W., . . . Young, B. (2018). Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trials. PEDIATRIC RHEUMATOLOGY, 16. doi:10.1186/s12969-018-0293-2DOI: 10.1186/s12969-018-0293-2
Smith, E. M. D., Lewandowski, L. B., Jorgensen, A. L., Phuti, A., Nourse, P., Scott, C., & Beresford, M. W. (2018). Growing international evidence for urinary biomarker panels identifying lupus nephritis in children - verification within the South African Paediatric Lupus Cohort. LUPUS, 27(14), 2190-2199. doi:10.1177/0961203318808376DOI: 10.1177/0961203318808376
Wright, R. D., & Beresford, M. W. (2018). Podocytes contribute, and respond, to the inflammatory environment in lupus nephritis. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 315(6), F1683-F1694. doi:10.1152/ajprenal.00512.2017DOI: 10.1152/ajprenal.00512.2017
Smith, E. M. D., Yin, P., Jorgensen, A. L., & Beresford, M. W. (2018). Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study. LUPUS, 27(13), 2020-2028. doi:10.1177/0961203318801526DOI: 10.1177/0961203318801526
Holland, M. J., Beresford, M. W., Feldman, B. M., Huggins, J., Norambuena, X., Silva, C. A., . . . Brunner, H. I. (2018). Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus Erythematosus. ARTHRITIS CARE & RESEARCH, 70(11), 1621-1629. doi:10.1002/acr.23531DOI: 10.1002/acr.23531
Peterknecht, E., Keasey, M. P., & Beresford, M. W. (2018). The effectiveness and safety of biological therapeutics in juvenile-onset systemic lupus erythematosus (JSLE): a systematic review. LUPUS, 27(13), 2135-2145. doi:10.1177/0961203318804879DOI: 10.1177/0961203318804879
Burke, L., Kirkham, J., Arnott, J., Gray, V., Peak, M., & WBeresford, M. (2018). The transition of adolescents with juvenile idiopathic arthritis or epilepsy from paediatric health-care services to adult health-care services: A scoping review of the literature and a synthesis of the evidence. JOURNAL OF CHILD HEALTH CARE, 22(3), 332-358. doi:10.1177/1367493517753330DOI: 10.1177/1367493517753330
Brunner, H. I., Holland, M., Beresford, M. W., Ardoin, S. P., Appenzeller, S., Silva, C. A., . . . Ying, J. (2018). American College of Rheumatology Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus. ARTHRITIS CARE & RESEARCH, 70(6), 813-822. doi:10.1002/acr.23557DOI: 10.1002/acr.23557
De Cock, D., Kearsley-Fleet, L., Davies, R., Baildam, E., Beresford, M., Foster, H., . . . Hyrich, K. (2018). BIOSIMILAR USE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS IN A REAL-WORLD SETTING IN THE UNITED KINGDOM. In ANNALS OF THE RHEUMATIC DISEASES Vol. 77 (pp. 485). doi:10.1136/annrheumdis-2018-eular.4477DOI: 10.1136/annrheumdis-2018-eular.4477
METHOTREXATE DRUG SURVIVAL AND ADVERSE EFFECTS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (Conference Paper)
Kearsley-Fleet, L., Gonzalez, L. V., Steinke, D., Davies, R., De Cock, D., Baildam, E., . . . Hyrich, K. L. (2018). METHOTREXATE DRUG SURVIVAL AND ADVERSE EFFECTS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 77 (pp. 493). doi:10.1136/annrheumdis-2018-eular.1276DOI: 10.1136/annrheumdis-2018-eular.1276
Ravelli, A., Consolaro, A., Horneff, G., Laxer, R. M., Lovell, D. J., Wulffraat, N. M., . . . Smolen, J. S. (2018). Treating juvenile idiopathic arthritis to target: recommendations of an international task force. ANNALS OF THE RHEUMATIC DISEASES, 77(6), 819-828. doi:10.1136/annrheumdis-2018-213030DOI: 10.1136/annrheumdis-2018-213030
Suwanchote, S., Rachayon, M., Rodsaward, P., Wongpiyabovorn, J., Deekajorndech, T., Wright, H. L., . . . Chiewchengchol, D. (2018). Anti-neutrophil cytoplasmic antibodies and their clinical significance. CLINICAL RHEUMATOLOGY, 37(4), 875-884. doi:10.1007/s10067-018-4062-xDOI: 10.1007/s10067-018-4062-x
Hedrich, C. M., Smith, E. M. D., & Beresford, M. W. (2018). Juvenile-onset systemic lupus erythematosus (jSLE) - Pathophysiological concepts and treatment options. Best Practice and Research: Clinical Rheumatology. doi:10.1016/j.berh.2018.02.001DOI: 10.1016/j.berh.2018.02.001
Ramanathan, K., Glaser, A., Lythgoe, H., Ong, J., Beresford, M. W., Midgley, A., & Wright, H. L. (2018). Neutrophil activation signature in juvenile idiopathic arthritis indicates the presence of low-density granulocytes. RHEUMATOLOGY, 57(3), 488-498. doi:10.1093/rheumatology/kex441DOI: 10.1093/rheumatology/kex441
Kuemmerle-Deschner, J. B., Hansmann, S., Wulffraat, N. M., Vastert, S. J., Hens, K., Anton, J., . . . Benseler, S. M. (2018). Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative. ANNALS OF THE RHEUMATIC DISEASES, 77(3), 319-327. doi:10.1136/annrheumdis-2017-211904DOI: 10.1136/annrheumdis-2017-211904
Smith, E. M. D., Yin, P., Jorgensen, A., & Beresford, M. (2018). Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study. Pediatric Rheumatology Online Journal, 16(1). doi:10.1186/s12969-018-0230-4DOI: 10.1186/s12969-018-0230-4
Beresford, M. W., & Ramanan, A. V. (2018). Child-centred research is the key to progress. NATURE REVIEWS RHEUMATOLOGY, 14(2), 69-70. doi:10.1038/nrrheum.2017.214DOI: 10.1038/nrrheum.2017.214
Lythgoe, H., Baildam, E., Beresford, M. W., Cleary, G., McCann, L. J., & Pain, C. E. (2018). Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma. RHEUMATOLOGY, 57(2), 398-401. doi:10.1093/rheumatology/kex382DOI: 10.1093/rheumatology/kex382
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial) (Journal article)
Ramanan, A. V., Dick, A. D., Jones, A. P., Guly, C., Hardwick, B., Hickey, H., . . . Beresford, M. W. (2018). A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial). BMC RHEUMATOLOGY, 2(1). doi:10.1186/s41927-018-0010-2DOI: 10.1186/s41927-018-0010-2
Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research. (Journal article)
McCann, L. J., Pilkington, C. A., Huber, A. M., Ravelli, A., Appelbe, D., Kirkham, J. J., . . . Beresford, M. W. (2018). Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research.. Annals of the rheumatic diseases, 77(2), 241-250. doi:10.1136/annrheumdis-2017-212141DOI: 10.1136/annrheumdis-2017-212141
Assessing the sensitivity of ISG and PEDBD criteria in a UK cohort of children and young people with Behcet's disease (Conference Paper)
Pain, C. E., Latham, E., Beresford, M. W., Fortune, F., Moots, R. J., Murphy, R., . . . Brogan, P. (2018). Assessing the sensitivity of ISG and PEDBD criteria in a UK cohort of children and young people with Behcet's disease. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 36 (pp. S186). Retrieved from https://www.webofscience.com/
BIOLOGIC REFRACTORY DISEASE IN A COHORT STUDY OF CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS FROM THE UNITED KINGDOM (Conference Paper)
Heaf, E., Kearsley-Fleet, L., Davies, R., De Cock, D., Baildam, E., Beresford, M. W., . . . Hyrich, K. L. (2018). BIOLOGIC REFRACTORY DISEASE IN A COHORT STUDY OF CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS FROM THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 57 (pp. 25). Retrieved from https://www.webofscience.com/
Decock, D., Davies, R., Kearsley-Fleet, L., Baildam, E., Beresford, M., Foster, H., . . . Hyrich, K. (2018). BIOSIMILAR USE IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS IN A REAL-WORLD SETTING IN THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 57. Retrieved from https://www.webofscience.com/
De Cock, D., Kearsley-Fleet, L., Baidam, E., Beresford, M., Foster, H., Southwood, T., . . . Hyrich, K. (2018). BIOSIMILAR USE IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS IN AREAL-WORLD SETTING IN THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 57. Retrieved from https://www.webofscience.com/
Biologic Refractory Disease in a Cohort Study of Children and Young People with Juvenile Idiopathic Arthritis from the United Kingdom (Conference Paper)
Heaf, E., Kearsley-Fleet, L., Davies, R., De Cock, D., Baildam, E., Beresford, M. W., . . . Hyrich, K. L. (2018). Biologic Refractory Disease in a Cohort Study of Children and Young People with Juvenile Idiopathic Arthritis from the United Kingdom. In ARTHRITIS & RHEUMATOLOGY Vol. 70. Retrieved from https://www.webofscience.com/
Beresford, M. (2018). SLE: SCIENCE IN PAEDIATRIC AND ADOLESCENT PATIENTS. In RHEUMATOLOGY Vol. 57. Retrieved from https://www.webofscience.com/
2017
Groot, N., de Graeff, N., Marks, S. D., Brogan, P., Avcin, T., Bader-Meunier, B., . . . Kamphuis, S. (2017). European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. ANNALS OF THE RHEUMATIC DISEASES, 76(12), 1965-1973. doi:10.1136/annrheumdis-2017-211898DOI: 10.1136/annrheumdis-2017-211898
USING A PRE-CLINIC SCREENING TOOL TO SUPPORT YOUNG PEOPLE WITH LUPUS IN PRIORITISING ISSUES FOR DISCUSSION IN CLINIC APPOINTMENTS (Conference Paper)
Wilson, E., Etheridge, J., Smith, E., & Beresford, M. W. (2017). USING A PRE-CLINIC SCREENING TOOL TO SUPPORT YOUNG PEOPLE WITH LUPUS IN PRIORITISING ISSUES FOR DISCUSSION IN CLINIC APPOINTMENTS. In RHEUMATOLOGY Vol. 56 (pp. 19-20). Retrieved from https://www.webofscience.com/
Smith, E. M. D., & Beresford, M. W. (2017). Urinary biomarkers in childhood lupus nephritis. CLINICAL IMMUNOLOGY, 185, 21-31. doi:10.1016/j.clim.2016.06.010DOI: 10.1016/j.clim.2016.06.010
Rider, L. G., Ruperto, N., Pistorio, A., Erman, B., Bayat, N., Lachenbruch, P. A., . . . Aggarwal, R. (2017). 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects. RHEUMATOLOGY, 56(11), 1884-1893. doi:10.1093/rheumatology/kex226DOI: 10.1093/rheumatology/kex226
Tansley, S. L., Simou, S., Shaddick, G., Betteridge, Z. E., Almeida, B., Gunawardena, H., . . . McHugh, N. J. (2017). Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort. JOURNAL OF AUTOIMMUNITY, 84, 55-64. doi:10.1016/j.jaut.2017.06.007DOI: 10.1016/j.jaut.2017.06.007
Groot, N., de Graeff, N., Avcin, T., Bader-Meunier, B., Brogan, P., Dolezalova, P., . . . Beresford, M. W. (2017). European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative. ANNALS OF THE RHEUMATIC DISEASES, 76(11), 1788-1796. doi:10.1136/annrheumdis-2016-210960DOI: 10.1136/annrheumdis-2016-210960
Developing an Education Resource for the paediatric BILAG index (Conference Paper)
Richards, E., Poutney, M., Holt, A., Prescott, D., Smith, E., Roberts, C., & Beresford, M. (2017). Developing an Education Resource for the paediatric BILAG index. In RHEUMATOLOGY Vol. 56. doi:10.1093/rheumatology/kex356.019DOI: 10.1093/rheumatology/kex356.019
Smith, E. M. D., Jorgensen, A. L., & Beresford, M. W. (2017). Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.. Lupus, 26(11), 1212-1217. doi:10.1177/0961203317702253DOI: 10.1177/0961203317702253
Lythgoe, H., Morgan, T., Heaf, E., Lloyd, O., Al-Abadi, E., Armon, K., . . . Beresford, M. W. (2017). Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis. LUPUS, 26(12), 1285-1290. doi:10.1177/0961203317700484DOI: 10.1177/0961203317700484
Oni, L., Beresford, M. W., Witte, D., Chatzitolios, A., Sebire, N., Abulaban, K., . . . Brunner, H. I. (2017). Inter-observer variability of the histological classification of lupus glomerulonephritis in children. LUPUS, 26(11), 1205-1211. doi:10.1177/0961203317706558DOI: 10.1177/0961203317706558
Brunner, H. I., Holland, M. J., Beresford, M. W., Ruperto, N., Ardoin, S. P., Appenzeller, S., . . . Ying, J. (2017). Validation of Flare Criteria for Children and Adolescents with Systemic Lupus Erythematosus. In ARTHRITIS & RHEUMATOLOGY Vol. 69. Retrieved from https://www.webofscience.com/
Ramanan, A. V., Dick, A. D., & Beresford, M. W. (2017). Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.. The New England journal of medicine, 377(8), 789-790. doi:10.1056/nejmc1708646DOI: 10.1056/nejmc1708646
Preface: Recent advances in autoimmune and auto-inflammatory diseases in childhood (Journal article)
Ramanan, A. V., & Beresford, M. W. (2017). Preface: Recent advances in autoimmune and auto-inflammatory diseases in childhood. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 31(4), 439-440. doi:10.1016/j.berh.2018.03.001DOI: 10.1016/j.berh.2018.03.001
Optimising the use of medicines to reduce acute kidney injury in children and babies (Journal article)
Oni, L., Hawcutt, D. B., Turner, M. A., Beresford, M. W., McWilliam, S., Barton, C., . . . Antoine, D. J. (2017). Optimising the use of medicines to reduce acute kidney injury in children and babies. Pharmacology and Therapeutics, 174, 55-62. doi:10.1016/j.pharmthera.2017.02.018DOI: 10.1016/j.pharmthera.2017.02.018
SHARE RECOMMENDATIONS ON SYSTEMIC VASCULITIDES (Conference Paper)
Beresford, M. W. (2017). SHARE RECOMMENDATIONS ON SYSTEMIC VASCULITIDES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 76 (pp. 9). doi:10.1136/annrheumdis-2017-eular.7205DOI: 10.1136/annrheumdis-2017-eular.7205
Ramanan, A. V., Dick, A. D., Jones, A. P., McKay, A., Williamson, P. R., Compeyrot-Lacassagne, S., . . . Grp, S. Y. C. A. M. O. R. E. S. (2017). Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis. New England Journal of Medicine, 376(17), 1637-1646. doi:10.1056/NEJMoa1614160DOI: 10.1056/NEJMoa1614160
PRESCRIBING PATTERNS IN JUVENILE IDIOPATHIC ARTHRITIS: A SURVEY OF CURRENT PRACTICE IN THE UNITED KINGDOM (Conference Paper)
Hawley, D. P., Foster, H. E., Beresford, M. W., Ramanan, A., Rapley, T., & McErlane, F. (2017). PRESCRIBING PATTERNS IN JUVENILE IDIOPATHIC ARTHRITIS: A SURVEY OF CURRENT PRACTICE IN THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 56 (pp. 168-169). Retrieved from https://www.webofscience.com/
Smith, E. M. D., Jorgensen, A. L., Midgley, A., Oni, L., Goilav, B., Putterman, C., . . . Beresford, M. W. (2017). International validation of a urinary biomarker panel for identification of active lupus nephritis in children.. Pediatric Nephrology, 32(2), 283-295. doi:10.1007/s00467-016-3485-3DOI: 10.1007/s00467-016-3485-3
Davies, R., Southwood, T., Kearsley-Fleet, L., Lunt, M., Baildam, E., Beresford, M. W., . . . Hyrich, K. L. (2017). Mortality rates are increased in patients with systemic juvenile idiopathic arthritis. ARCHIVES OF DISEASE IN CHILDHOOD, 102(2). doi:10.1136/archdischild-2016-311571DOI: 10.1136/archdischild-2016-311571
BIOSIMILAR USE IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS IN A REAL-WORLD SETTING IN THE UNITED KINGDOM (Conference Paper)
De Cock, D., Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2017). BIOSIMILAR USE IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS IN A REAL-WORLD SETTING IN THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 56 (pp. 16). Retrieved from https://www.webofscience.com/
BRITISH PAEDIATRIC SURVEILLANCE UNIT (BPSU) STUDY OF BEHCET'S SYNDROME IN CHILDREN AND YOUNG PEOPLE IN THE UNITED KINGDOM (Conference Paper)
Rice, H., Beresford, M. W., Brogan, P., Fortune, F., Moots, R. J., Murphy, R., & Pain, C. E. (2017). BRITISH PAEDIATRIC SURVEILLANCE UNIT (BPSU) STUDY OF BEHCET'S SYNDROME IN CHILDREN AND YOUNG PEOPLE IN THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 56. Retrieved from https://www.webofscience.com/
Biosimilar Use in Children and Young People with Juvenile Idiopathic Arthritis in a Real-World Setting in the United Kingdom (Conference Paper)
De Cock, D., Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2017). Biosimilar Use in Children and Young People with Juvenile Idiopathic Arthritis in a Real-World Setting in the United Kingdom. In ARTHRITIS & RHEUMATOLOGY Vol. 69. Retrieved from https://www.webofscience.com/
CLINICAL FACTORS ASSOCIATED WITH NON-RESPONSE TO METHOTREXATE IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE CHILDHOOD ARTHRITIS RESPONSE TO TREATMENT CONSORTIUM (Conference Paper)
Sampath, S., Sergeant, J. C., Viatte, S., Carrasco, R., Cobb, J., Smith, S. L., . . . Thomson, W. (2017). CLINICAL FACTORS ASSOCIATED WITH NON-RESPONSE TO METHOTREXATE IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE CHILDHOOD ARTHRITIS RESPONSE TO TREATMENT CONSORTIUM. In RHEUMATOLOGY Vol. 56. Retrieved from https://www.webofscience.com/
DEVELOPING A UK/ROI STUDY OF THE INCIDENCE OF JSLE IN CHILDREN AND YOUNG PEOPLE AND THEIR ACCESS TO CARE: A COLLABORATIVE APPROACH (Conference Paper)
Lythgoe, H., Smith, E., Pain, C., Murphy, R., Killeen, O., Pilkington, C., & Beresford, M. W. (2017). DEVELOPING A UK/ROI STUDY OF THE INCIDENCE OF JSLE IN CHILDREN AND YOUNG PEOPLE AND THEIR ACCESS TO CARE: A COLLABORATIVE APPROACH. In RHEUMATOLOGY Vol. 56 (pp. 3-+). Retrieved from https://www.webofscience.com/
DISEASE ACTIVITY STATUS IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (Conference Paper)
Abdelrahman, N., Beresford, M. W., & Leone, V. (2017). DISEASE ACTIVITY STATUS IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS. In RHEUMATOLOGY Vol. 56 (pp. 16-+). Retrieved from https://www.webofscience.com/
GENOME-WIDE ASSOCIATION STUDY OF METHOTREXATE NON-RESPONSE IN JUVENILE IDIOPATHIC ARTHRITIS (Conference Paper)
Sampath, S., Viatte, S., Smith, S. L., Cobb, J., Hinks, A., Hyrich, K. L., . . . Thomson, W. (2017). GENOME-WIDE ASSOCIATION STUDY OF METHOTREXATE NON-RESPONSE IN JUVENILE IDIOPATHIC ARTHRITIS. In RHEUMATOLOGY Vol. 56 (pp. 14-15). Retrieved from https://www.webofscience.com/
JUVENILE-ONSET LUPUS NEPHRITIS: CHARACTERISING THE ROLE OF THE GLOMERULAR ENDOTHELIAL CELLS IN URINARY BIOMARKER PRODUCTION (Conference Paper)
Dimou, P., Peak, M., Midgley, A., Satchell, S. C., Wright, R. D., & Beresford, M. W. (2017). JUVENILE-ONSET LUPUS NEPHRITIS: CHARACTERISING THE ROLE OF THE GLOMERULAR ENDOTHELIAL CELLS IN URINARY BIOMARKER PRODUCTION. In RHEUMATOLOGY Vol. 56. Retrieved from https://www.webofscience.com/
LUPUS AND YOU: DEVELOPING A WORKSHOP FOR YOUNG PEOPLE WITH LUPUS AND THEIR FAMILIES (Conference Paper)
Wilson, E., Lythgoe, H., Smith, E., Preston, J., & Beresford, M. W. (2017). LUPUS AND YOU: DEVELOPING A WORKSHOP FOR YOUNG PEOPLE WITH LUPUS AND THEIR FAMILIES. In RHEUMATOLOGY Vol. 56. Retrieved from https://www.webofscience.com/
SHORT-TERM OUTCOMES IN PATIENTS WITH SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH EITHER TOCILIZUMAB OR ANAKINRA IN A REAL-WORLD SETTING IN THE UNITED KINGDOM (Conference Paper)
Kearsley-Fleet, L., De Cock, D., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2017). SHORT-TERM OUTCOMES IN PATIENTS WITH SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH EITHER TOCILIZUMAB OR ANAKINRA IN A REAL-WORLD SETTING IN THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 56. Retrieved from https://www.webofscience.com/
Short-Term Outcomes in Patients with Systemic-Onset Juvenile Idiopathic Arthritis Treated with Either Tocilizumab or Anakinra in a Real-World Setting in the United Kingdom (Conference Paper)
Kearsley-Fleet, L., De Cock, D., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2017). Short-Term Outcomes in Patients with Systemic-Onset Juvenile Idiopathic Arthritis Treated with Either Tocilizumab or Anakinra in a Real-World Setting in the United Kingdom. In ARTHRITIS & RHEUMATOLOGY Vol. 69. Retrieved from https://www.webofscience.com/
THE INFLUENCE OF RITUXIMAB ON THE METABOLOME OF JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS (Conference Paper)
Glaser, A., Wright, H. L., Midgley, A., Phelan, M. M., Peak, M., & Beresford, M. W. (2017). THE INFLUENCE OF RITUXIMAB ON THE METABOLOME OF JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS. In RHEUMATOLOGY Vol. 56. Retrieved from https://www.webofscience.com/
Tartrate-Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus (Journal article)
An, J., Briggs, T. A., Dumax-Vorzet, A., Alarcon-Riquelme, M. E., Belot, A., Beresford, M., . . . Elkon, K. B. (2017). Tartrate-Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus. ARTHRITIS & RHEUMATOLOGY, 69(1), 131-142. doi:10.1002/art.39810DOI: 10.1002/art.39810
Ramos-Martin, V., Neely, M. N., Padmore, K., Peak, M., Beresford, M. W., Turner, M. A., . . . Hope, W. W. (2017). Tools for the Individualized Therapy of Teicoplanin for Neonates and Children. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61(10). doi:10.1128/AAC.00707-17DOI: 10.1128/AAC.00707-17
Macfarlane, K., Cleary, G., Baildam, E., McCann, L., Beresford, M. W., & Pain, C. E. (2017). UNUSUAL PRESENTATIONS OF PAEDIATRIC SARCOID. In RHEUMATOLOGY Vol. 56 (pp. 17-18). Retrieved from https://www.webofscience.com/
Validation of Clinically Relevant Improvement in Children and Adolescents with cSLE (Conference Paper)
Aydin, P. O. A., Holland, M. J., Appenzeller, S., Ardoin, S. P., Avcin, T., Beresford, M. W., . . . Brunner, H. I. (2017). Validation of Clinically Relevant Improvement in Children and Adolescents with cSLE. In ARTHRITIS & RHEUMATOLOGY Vol. 69. Retrieved from https://www.webofscience.com/
2016
Ambrose, N., Morgan, T. A., Galloway, J., Ionnoau, Y., Beresford, M. W., & Isenberg, D. A. (2016). Differences in disease phenotype and severity in SLE across age groups. LUPUS, 25(14), 1542-1550. doi:10.1177/0961203316644333DOI: 10.1177/0961203316644333
Ramos-Martín, V., Neely, M. N., McGowan, P., Siner, S., Padmore, K., Peak, M., . . . Hope, W. W. (2016). Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy.. The Journal of antimicrobial chemotherapy, 71(11), 3168-3178. doi:10.1093/jac/dkw295DOI: 10.1093/jac/dkw295
Sampath, S., Sergeant, J. C., Viatte, S., Carrasco, R., Cobb, J., Smith, S., . . . Thomson, W. (2016). Clinical Factors Associated with Non-Response to Methotrexate in Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis Response to Treatment Consortium. In ARTHRITIS & RHEUMATOLOGY Vol. 68. Retrieved from https://www.webofscience.com/
FACTORS ASSOCIATED WITH CHOICE OF FIRST BIOLOGIC AMONG CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: A COMBINED ANALYSIS FROM TWO UK PAEDIATRIC BIOLOGIC REGISTERS (Journal article)
Kearsley-Fleet, L., Davies, R., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2015). FACTORS ASSOCIATED WITH CHOICE OF FIRST BIOLOGIC AMONG CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: A COMBINED ANALYSIS FROM TWO UK PAEDIATRIC BIOLOGIC REGISTERS. RHEUMATOLOGY, 54, 156. Retrieved from https://www.webofscience.com/
Kearsley-Fleet, L., Davies, R., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2016). Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers. RHEUMATOLOGY, 55(9), 1556-1565. doi:10.1093/rheumatology/kev429DOI: 10.1093/rheumatology/kev429
Patel, M., Oni, L., Midgley, A., Smith, E., Tullus, K., Marks, S. D., . . . Beresford, M. W. (2016). Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis. LUPUS, 25(9), 1040-1044. doi:10.1177/0961203316631634DOI: 10.1177/0961203316631634
Ramanan, A. V., Dick, A. D., Jones, A. P., McKay, A., Williamson, P. R., Compeyrot-Lacassagne, S., . . . Beresford, M. W. (2016). ADALIMUMAB IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS: THE SYCAMORE TRIAL. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 264-265). doi:10.1136/annrheumdis-2016-eular.6053DOI: 10.1136/annrheumdis-2016-eular.6053
EFFECT OF TYPE 1 AND 2 INTERFERONS ON NEUTROPHIL APOPTOSIS IN NAIVE AND TNF ALPHA PRIMED NEUTROPHILS (Conference Paper)
Irwin, S., Midgley, A., Wright, R., Peak, M., & Beresford, M. (2016). EFFECT OF TYPE 1 AND 2 INTERFERONS ON NEUTROPHIL APOPTOSIS IN NAIVE AND TNF ALPHA PRIMED NEUTROPHILS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 428). doi:10.1136/annrheumdis-2016-eular.4236DOI: 10.1136/annrheumdis-2016-eular.4236
Lythgoe, H., Morgan, T., Heaf, E., Lloyd, O., & Beresford, M. W. (2016). EVALUATION OF THE ACR AND SLICC CLASSIFICATION CRITERIA IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL ANALYSIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 139). doi:10.1136/annrheumdis-2016-eular.3430DOI: 10.1136/annrheumdis-2016-eular.3430
Dimou, P., Midgley, A., Peak, M., Wright, R. D., & Beresford, M. W. (2016). INVESTIGATING THE NEUTROPHIL-MACROPHAGE INTERPLAY IN JUVENILE LUPUS NEPHRITIS PATHOGENESIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 914-915). doi:10.1136/annrheumdis-2016-eular.5116DOI: 10.1136/annrheumdis-2016-eular.5116
INVESTIGATING THE PHAGOCYTIC POTENTIAL OF NEUTROPHILS FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS (Conference Paper)
Glaser, A. E. A., Wright, H. L., Midgley, A., Peak, M., & Beresford, M. W. (2016). INVESTIGATING THE PHAGOCYTIC POTENTIAL OF NEUTROPHILS FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 941). doi:10.1136/annrheumdis-2016-eular.5342DOI: 10.1136/annrheumdis-2016-eular.5342
Thorbinson, C., Oni, L., Smith, E., Midgley, A., & Beresford, M. W. (2016). Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus. PEDIATRIC DRUGS, 18(3), 181-195. doi:10.1007/s40272-016-0170-8DOI: 10.1007/s40272-016-0170-8
SHARE RECOMMENDATIONS ON CONNECTIVE TISSUE DISEASES (Conference Paper)
Beresford, M. W. (2016). SHARE RECOMMENDATIONS ON CONNECTIVE TISSUE DISEASES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 16). doi:10.1136/annrheumdis-2016-eular.6387DOI: 10.1136/annrheumdis-2016-eular.6387
Midgley, A., & Beresford, M. W. (2016). Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity. LUPUS, 25(4), 407-411. doi:10.1177/0961203315608959DOI: 10.1177/0961203315608959
Chiewchengchol, D., Wright, H. L., Thomas, H. B., Lam, C. W., Roberts, K. J., Hirankarn, N., . . . Edwards, S. W. (2016). Differential changes in gene expression in human neutrophils following TNF-alpha stimulation: Up-regulation of anti-apoptotic proteins and down-regulation of proteins involved in death receptor signaling. IMMUNITY INFLAMMATION AND DISEASE, 4(1), 35-44. doi:10.1002/iid3.90DOI: 10.1002/iid3.90
Tansley, S. L., Tansley, S. L., Dunphy, J., Jobling, A. A. C., Carrasco, R., Midgley, A., . . . McHugh, N. J. (2016). A DENSE FINE SPECKLE PATTERN ON IMMUNOFLUORESCENCE IS STRONGLY ASSOCIATED WITH THE DEVELOPMENT OF UVEITIS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS. In RHEUMATOLOGY Vol. 55 (pp. 57-58). Retrieved from https://www.webofscience.com/
ACTIVATION OF THE STAT1 PATHWAY BY TYPE 1 AND 2 INTERFERONS AND SUBSEQUENT EFFECT ON NEUTROPHIL APOPTOSIS (Conference Paper)
Irwin, S., Midgley, A., Wright, R. D., Peak, M., & Beresford, M. W. (2016). ACTIVATION OF THE STAT1 PATHWAY BY TYPE 1 AND 2 INTERFERONS AND SUBSEQUENT EFFECT ON NEUTROPHIL APOPTOSIS. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 34 (pp. S58). Retrieved from https://www.webofscience.com/
Holland, M. J., Beresford, M. W., Ruperto, N., Watts, A., Wiley, K., Cortis, E., . . . Brunner, H. I. (2016). Frequency of the Systemic Lupus Collaborating Clinics- Damage Index Items in Three Registries of Childhood-Onset Systemic Lupus Erythematosus. In ARTHRITIS & RHEUMATOLOGY Vol. 68. Retrieved from https://www.webofscience.com/
JUVENILE-ONSET LUPUS NEPHRITIS: INVESTIGATING THE ROLE OF THE GLOMERULAR ENDOTHELIAL CELLS IN NOVEL URINE BIOMARKER PRODUCTION (Conference Paper)
Dimou, P., Midgley, A., Peak, M., Satchell, S. C., Wright, R. D., & Beresford, M. W. (2016). JUVENILE-ONSET LUPUS NEPHRITIS: INVESTIGATING THE ROLE OF THE GLOMERULAR ENDOTHELIAL CELLS IN NOVEL URINE BIOMARKER PRODUCTION. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 34 (pp. S88). Retrieved from https://www.webofscience.com/
ROLE OF THE PODOCYTES IN BIOMARKER PRODUCTION IN JUVENILE LUPUS NEPHRITIS (Conference Paper)
Wright, R., & Beresford, M. W. (2016). ROLE OF THE PODOCYTES IN BIOMARKER PRODUCTION IN JUVENILE LUPUS NEPHRITIS. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 34 (pp. S72). Retrieved from https://www.webofscience.com/
Rituximab Should be Considered in Rheumatoid Factor Negative Poly-Articular Juvenile Idiopathic Arthritis (Conference Paper)
Sampath, S., McCann, L. J., Beresford, M. W., Baildam, E., Sergeant, J. C., Thomson, W., . . . Hyrich, K. L. (2016). Rituximab Should be Considered in Rheumatoid Factor Negative Poly-Articular Juvenile Idiopathic Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 68. Retrieved from https://www.webofscience.com/
STUDYING THE POTENTIAL OF NEUTROPHILS FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS FOR PHAGOCYTOSIS (Conference Paper)
Glaser, A., Wright, H. L., Wright, R. D., Midgley, A., Peak, M., & Beresford, M. W. (2016). STUDYING THE POTENTIAL OF NEUTROPHILS FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS FOR PHAGOCYTOSIS. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 34 (pp. S57). Retrieved from https://www.webofscience.com/
2015
Juvenile-onset systemic lupus erythematosus: how to diagnose and manage (Journal article)
Oni, L., Thorbinson, C., & Beresford, M. W. (2015). Juvenile-onset systemic lupus erythematosus: how to diagnose and manage. Paediatrics and Child Health, 25(12), 555-560. doi:10.1016/j.paed.2015.07.005DOI: 10.1016/j.paed.2015.07.005
Co-existence of juvenile-onset systemic lupus erythematosus and juvenile myasthenia gravis (Journal article)
Sampath, S., McCann, L. J., McDonagh, J., Cleary, G., Spinty, S., Pain, C. E., . . . Beresford, M. W. (2015). Co-existence of juvenile-onset systemic lupus erythematosus and juvenile myasthenia gravis. LUPUS, 24(13), 1462-1463. doi:10.1177/0961203315591030DOI: 10.1177/0961203315591030
Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study (Journal article)
Hawwa, A. F., AlBawab, A., Rooney, M., Wedderburn, L. R., Beresford, M. W., & McElnay, J. C. (2015). Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study. ARTHRITIS RESEARCH & THERAPY, 17. doi:10.1186/s13075-015-0814-zDOI: 10.1186/s13075-015-0814-z
Development of an internationally agreed minimal dataset for juvenile dermatomyositis (JDM) for clinical and research use (Journal article)
McCann, L. J., Kirkham, J. J., Wedderburn, L. R., Pilkington, C., Huber, A. M., Ravelli, A., . . . Beresford, M. W. (2015). Development of an internationally agreed minimal dataset for juvenile dermatomyositis (JDM) for clinical and research use. TRIALS, 16. doi:10.1186/s13063-015-0784-0DOI: 10.1186/s13063-015-0784-0
DEMONSTRATION OF AN "EXCELLENT" BIOMARKER PANEL FOR IDENTIFYING ACTIVE LUPUS NEPHRITIS IN CHILDREN (Conference Paper)
Smith, E., Oni, L., Midgley, A., Ekdawy, D., Corkhill, R., Jones, C., . . . Beresford, M. W. (2015). DEMONSTRATION OF AN "EXCELLENT" BIOMARKER PANEL FOR IDENTIFYING ACTIVE LUPUS NEPHRITIS IN CHILDREN. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 331). doi:10.1136/annrheumdis-2015-eular.3352DOI: 10.1136/annrheumdis-2015-eular.3352
DEVELOPMENT OF AN INTERNATIONALLY AGREED MINIMAL DATASET FOR JUVENILE DERMATOMYOSITIS (JDM) FOR CLINICAL AND RESEARCH USE (Conference Paper)
McCann, L., Wedderburn, L. R., Pilkington, C., Huber, A. M., Ravelli, A., Williamson, P., . . . Beresford, M. W. (2015). DEVELOPMENT OF AN INTERNATIONALLY AGREED MINIMAL DATASET FOR JUVENILE DERMATOMYOSITIS (JDM) FOR CLINICAL AND RESEARCH USE. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 837-838). doi:10.1136/annrheumdis-2015-eular.2479DOI: 10.1136/annrheumdis-2015-eular.2479
EFFECTS OF INTERFERON ALPHA ON NEUTROPHIL APOPTOSIS AND CASPASE 3 CLEAVAGE (Conference Paper)
Irwin, S., Midgley, A., & Beresford, M. W. (2015). EFFECTS OF INTERFERON ALPHA ON NEUTROPHIL APOPTOSIS AND CASPASE 3 CLEAVAGE. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 915). doi:10.1136/annrheumdis-2015-eular.3415DOI: 10.1136/annrheumdis-2015-eular.3415
EXPLORING THE RELATIONSHIP OF URINARY VASCULAR CELL ADHESION MOLECULE-1 WITH LUPUS NEPHRITIS DISEASE ACTIVITY OVER TIME (Conference Paper)
Ekdawy, D., Smith, E., Oni, L., Midgley, A., Corkhill, R., Jones, C., . . . Beresford, M. (2015). EXPLORING THE RELATIONSHIP OF URINARY VASCULAR CELL ADHESION MOLECULE-1 WITH LUPUS NEPHRITIS DISEASE ACTIVITY OVER TIME. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 610). doi:10.1136/annrheumdis-2015-eular.4558DOI: 10.1136/annrheumdis-2015-eular.4558
EXPRESSION OF LOW DENSITY GRANULOCYTES AND HISTONE CITRULLINATION IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS AND JUVENILE IDIOPATHIC ARTHRITIS (Conference Paper)
Ong, J., Midgley, A., & Beresford, M. (2015). EXPRESSION OF LOW DENSITY GRANULOCYTES AND HISTONE CITRULLINATION IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS AND JUVENILE IDIOPATHIC ARTHRITIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 146). doi:10.1136/annrheumdis-2015-eular.5002DOI: 10.1136/annrheumdis-2015-eular.5002
FINAL EVIDENCE-BASED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF PAEDIATRIC VASCULITIDES (Conference Paper)
De Graeff, N., Groot, N., Kamphuis, S., Avcin, T., Bader-Meunier, B., Dolezalova, P., . . . Beresford, M. (2015). FINAL EVIDENCE-BASED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF PAEDIATRIC VASCULITIDES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 522-523). doi:10.1136/annrheumdis-2015-eular.6334DOI: 10.1136/annrheumdis-2015-eular.6334
INHIBITION OF IFN ALPHA SIGNALLING REDUCES HMGB1 TRANSLOCATION AND NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) (Conference Paper)
Midgley, A., & Beresford, M. W. (2015). INHIBITION OF IFN ALPHA SIGNALLING REDUCES HMGB1 TRANSLOCATION AND NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE). In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 204-205). doi:10.1136/annrheumdis-2015-eular.5537DOI: 10.1136/annrheumdis-2015-eular.5537
DEVELOPING A URINARY BIOMARKER PANEL FOR MONITORING LUPUS NEPHRITIS DISEASE ACTIVITY (Conference Paper)
Smith, E. M. D., Corkhill, R., Midgley, A., Watson, L., Jones, C., Marks, S. D., . . . Beresford, M. W. (2015). DEVELOPING A URINARY BIOMARKER PANEL FOR MONITORING LUPUS NEPHRITIS DISEASE ACTIVITY. In RHEUMATOLOGY Vol. 54 (pp. 3). doi:10.1093/rheumatology/keu492DOI: 10.1093/rheumatology/keu492
FACTORS ASSOCIATED WITH CHOICE OF FIRST BIOLOGIC AMONG CHILDREN WITH JIA: A COMBINED ANALYSIS FROM TWO UK PAEDIATRIC BIOLOGIC REGISTERS (Conference Paper)
Kearsley-Fleet, L., Davies, R., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2015). FACTORS ASSOCIATED WITH CHOICE OF FIRST BIOLOGIC AMONG CHILDREN WITH JIA: A COMBINED ANALYSIS FROM TWO UK PAEDIATRIC BIOLOGIC REGISTERS. In RHEUMATOLOGY Vol. 54 (pp. 5). doi:10.1093/rheumatology/keu494DOI: 10.1093/rheumatology/keu494
FELTY'S SYNDROME IN RHEUMATOID FACTOR POSITIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: THE ROLE OF RITUXIMAB (Conference Paper)
Brown, L. E., Sampath, S., Ryan, F., Pain, C. E., McCann, L. J., Cleary, G., . . . Baildam, E. M. (2015). FELTY'S SYNDROME IN RHEUMATOID FACTOR POSITIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: THE ROLE OF RITUXIMAB. In RHEUMATOLOGY Vol. 54 (pp. 7). doi:10.1093/rheumatology/keu499DOI: 10.1093/rheumatology/keu499
JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS WITH OVERLAP FEATURES OF ANCA-ASSOCIATED VASCULITIS : A CASE REPORT (Conference Paper)
Brown, L. E., Sampath, S., Ryan, F., Cleary, G., McCann, L., Pain, C., . . . Baildam, E. (2015). JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS WITH OVERLAP FEATURES OF ANCA-ASSOCIATED VASCULITIS : A CASE REPORT. In RHEUMATOLOGY Vol. 54 (pp. 11). doi:10.1093/rheumatology/keu508DOI: 10.1093/rheumatology/keu508
Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in Juvenile-onset Systemic Lupus Erythematosus (Journal article)
Ballantine, L., Midgley, A., Harris, D., Richards, E., Burgess, S., & Beresford, M. W. (2015). Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in Juvenile-onset Systemic Lupus Erythematosus. PEDIATRIC RHEUMATOLOGY, 13. doi:10.1186/s12969-015-0007-yDOI: 10.1186/s12969-015-0007-y
Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa (Journal article)
Hampson, L. V., Whitehead, J., Eleftheriou, D., Tudur-Smith, C., Jones, R., Jayne, D., . . . Brogan, P. A. (2015). Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa. PLOS ONE, 10(3). doi:10.1371/journal.pone.0120981DOI: 10.1371/journal.pone.0120981
Smith, E. M. D., Foster, H. E., & Beresford, M. W. (2015). The development and assessment of biological treatments for children. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 79(3), 379-394. doi:10.1111/bcp.12406DOI: 10.1111/bcp.12406
Characterization of Human Disease Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1 (Journal article)
Crow, Y. J., Chase, D. S., Schmidt, J. L., Szynkiewicz, M., Forte, G. M. A., Gornall, H. L., . . . Rice, G. I. (2015). Characterization of Human Disease Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 167(2), 296-312. doi:10.1002/ajmg.a.36887DOI: 10.1002/ajmg.a.36887
Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature (Journal article)
Chiewchengchol, D., Murphy, R., Edwards, S. W., & Beresford, M. W. (2015). Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature. PEDIATRIC RHEUMATOLOGY, 13. doi:10.1186/1546-0096-13-1DOI: 10.1186/1546-0096-13-1
AN EXCELLENT BIOMARKER PANEL FOR IDENTIFICATION OF ACTIVE LUPUS NEPHRITIS IN CHILDREN (Conference Paper)
Smith, E. M. D. D., Oni, L., Midgley, A., Tullus, K., Pilkington, C., Marks, S., . . . Beresford, M. W. (2015). AN EXCELLENT BIOMARKER PANEL FOR IDENTIFICATION OF ACTIVE LUPUS NEPHRITIS IN CHILDREN. In NEPHROLOGY DIALYSIS TRANSPLANTATION Vol. 30. doi:10.1093/ndt/gfv153.5DOI: 10.1093/ndt/gfv153.5
Connective tissue diseases in children (Chapter)
Wedderburn, L. R., Pilkington, C. A., & Beresford, M. W. (2015). Connective tissue diseases in children. In Rheumatology (pp. 868-875). Elsevier. doi:10.1016/b978-0-323-09138-1.00105-4DOI: 10.1016/b978-0-323-09138-1.00105-4
Development of an Internationally Agreed Minimal Dataset for Juvenile Dermatomyositis (JDM) for Clinical and Research Use (Journal article)
McCann, L. J., Wedderburn, L. R., Pilkington, C., Huber, A. M., Ravelli, A., Kirkham, J., . . . Beresford, M. W. (2015). Development of an Internationally Agreed Minimal Dataset for Juvenile Dermatomyositis (JDM) for Clinical and Research Use. ARTHRITIS & RHEUMATOLOGY, 67. Retrieved from https://www.webofscience.com/
NGS Panel for the Detection of Monogenic SLE in Children: Initial Results (Journal article)
Belot, A., Rice, G., Mathieu, A. -L., Bader-Meunier, B., Walzer, T., Briggs, T. A., . . . Crow, Y. (2015). NGS Panel for the Detection of Monogenic SLE in Children: Initial Results. ARTHRITIS & RHEUMATOLOGY, 67. Retrieved from https://www.webofscience.com/
RESPONSE TO RITUXIMAB IN PATIENTS WITH REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM A NATIONAL MULTI-CENTRE REGISTER (Conference Paper)
Sutton, E. J., Watson, K. D., Isenberg, D. A., Rahman, A., Jayne, D., Gordon, C., . . . Bruce, I. N. (2015). RESPONSE TO RITUXIMAB IN PATIENTS WITH REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM A NATIONAL MULTI-CENTRE REGISTER. In RHEUMATOLOGY Vol. 54 (pp. 30-31). Retrieved from https://www.webofscience.com/
THE RENAL STATUS OF THE UK JUVENILE-SLE COHORT (Conference Paper)
Oni, L., Richards, E., Smith, E., & Beresford, M. W. (2015). THE RENAL STATUS OF THE UK JUVENILE-SLE COHORT. In NEPHROLOGY DIALYSIS TRANSPLANTATION Vol. 30. doi:10.1093/ndt/gfv203.2DOI: 10.1093/ndt/gfv203.2
The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE (Journal article)
Watson, L., Beresford, M., Maynes, C., Pilkington, C., Marks, S. D., Glackin, Y., & Tullus, K. (2015). The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE. Lupus, 24(1), 10-17. doi:10.1177/0961203314547793DOI: 10.1177/0961203314547793
The protective effect of GM-CSF on serum-induced neutrophil apoptosis in juvenile systemic lupus erythematosus patients (Journal article)
Chiewchengchol, D., Midgley, A., Sodsai, P., Deekajorndech, T., Hirankarn, N., Beresford, M. W., & Edwards, S. W. (2015). The protective effect of GM-CSF on serum-induced neutrophil apoptosis in juvenile systemic lupus erythematosus patients. CLINICAL RHEUMATOLOGY, 34(1), 85-91. doi:10.1007/s10067-014-2800-2DOI: 10.1007/s10067-014-2800-2
2014
Population Pharmacokinetics of Teicoplanin in Children (Journal article)
Ramos-Martin, V., Paulus, S., Siner, S., Scott, E., Padmore, K., Newland, P., . . . Hope, W. W. (2014). Population Pharmacokinetics of Teicoplanin in Children. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 58(11), 6920-6927. doi:10.1128/AAC.03685-14DOI: 10.1128/AAC.03685-14
Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients (Journal article)
Chiewchengchol, D., Murphy, R., Morgan, T., Edwards, S. W., Leone, V., Friswell, M., . . . Grp, U. K. J. S. L. E. S. (2014). Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients. RHEUMATOLOGY, 53(8), 1504-1512. doi:10.1093/rheumatology/keu137DOI: 10.1093/rheumatology/keu137
Developing a provisional, international Minimal Dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research (Journal article)
McCann, L. J., Arnold, K., Pilkington, C. A., Huber, A. M., Ravelli, A., Beard, L., . . . Wedderburn, L. R. (2014). Developing a provisional, international Minimal Dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research. PEDIATRIC RHEUMATOLOGY, 12. doi:10.1186/1546-0096-12-31DOI: 10.1186/1546-0096-12-31
New insights into the pathogenesis and management of lupus in children (Journal article)
Midgley, A., Watson, L., & Beresford, M. W. (2014). New insights into the pathogenesis and management of lupus in children. ARCHIVES OF DISEASE IN CHILDHOOD, 99(6), 563-567. doi:10.1136/archdischild-2013-304397DOI: 10.1136/archdischild-2013-304397
Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study (Journal article)
Watson, L., Tullus, K., Pilkington, C., Chesters, C., Marks, S., Newland, P., . . . Beresford, M. (2014). Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study. Pediatric Nephrology, 29(3), 397-405. doi:10.1007/s00467-013-2668-4DOI: 10.1007/s00467-013-2668-4
Smith, E. M. D., Foster, H. E., Gray, W. K., Taylor-Robinson, D., & Beresford, M. W. (2014). Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE Cohort Study. RHEUMATOLOGY, 53(3), 557-561. doi:10.1093/rheumatology/ket402DOI: 10.1093/rheumatology/ket402
A Novel Dried Blood Spot-LCMS Method for the Quantification of Methotrexate Polyglutamates as a Potential Marker for Methotrexate Use in Children (Journal article)
Hawwa, A. F., AlBawab, A., Rooney, M., Wedderburn, L. R., Beresford, M. W., & McElnay, J. C. (2014). A Novel Dried Blood Spot-LCMS Method for the Quantification of Methotrexate Polyglutamates as a Potential Marker for Methotrexate Use in Children. PLOS ONE, 9(2). doi:10.1371/journal.pone.0089908DOI: 10.1371/journal.pone.0089908
The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus (Journal article)
Ballantine, L. E., Ong, J., Midgley, A., Watson, L., Flanagan, B., & Beresford, M. (2014). The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus. Pediatric Rheumatology, 12. doi:10.1186/1546-0096-12-4DOI: 10.1186/1546-0096-12-4
A Randomised Controlled Trial of the Clinical Effectiveness, Safety and Cost-Effectiveness of Adalimumab in Combination with Methotrexate for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis (Journal article)
Ramanan, A. V., Dick, A. D., McKay, A., Jones, A., Williamson, P., Compeyrot-Lacassagne, S., . . . Beresford, M. W. (2015). A Randomised Controlled Trial of the Clinical Effectiveness, Safety and Cost-Effectiveness of Adalimumab in Combination with Methotrexate for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis. ARTHRITIS & RHEUMATOLOGY, 67. Retrieved from https://www.webofscience.com/
A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial) (Journal article)
Ramanan, A. V., Dick, A. D., Benton, D., Compeyrot-Lacassagne, S., Dawoud, D., Hardwick, B., . . . The SYCAMORE Trial Management Group. (2014). A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial). Trials, 15. doi:10.1186/1745-6215-15-14DOI: 10.1186/1745-6215-15-14
A COMPARISON OF THE AMERICAN COLLEGE OF RHEUMATOLOGY AND THE SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS CLASSIFICATION CRITERIA (Conference Paper)
Lloyd, O., Heaf, E., Morgan, T., Roberts, C., McCann, L., & Beresford, M. W. (2014). A COMPARISON OF THE AMERICAN COLLEGE OF RHEUMATOLOGY AND THE SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS CLASSIFICATION CRITERIA. In RHEUMATOLOGY Vol. 53 (pp. 13). Retrieved from https://www.webofscience.com/
A SYSTEMATIC LITERATURE REVIEW ON DIAGNOSIS AND TREATMENT OF PAEDIATRIC RHEUMATIC DISEASES: A SHARED INITIATIVE (Conference Paper)
Groot, N., Boom, V., de Graeff, N., Enders, F. B., ter Haar, N., Sperotto, F., . . . Wulffraat, N. M. (2014). A SYSTEMATIC LITERATURE REVIEW ON DIAGNOSIS AND TREATMENT OF PAEDIATRIC RHEUMATIC DISEASES: A SHARED INITIATIVE. In RHEUMATOLOGY Vol. 53 (pp. 13). Retrieved from https://www.webofscience.com/
A SYSTEMATIC LITERATURE REVIEW ON DIAGNOSIS AND TREATMENT OF PAEDIATRIC RHEUMATIC DISEASES: A SHARED INITIATIVE (Conference Paper)
Groot, N., Boom, V., de Graeff, N., Enders, F. B., ter Haar, N., Sperotto, F., . . . Wulffraat, N. M. (2014). A SYSTEMATIC LITERATURE REVIEW ON DIAGNOSIS AND TREATMENT OF PAEDIATRIC RHEUMATIC DISEASES: A SHARED INITIATIVE. In RHEUMATOLOGY Vol. 53 (pp. 22). Retrieved from https://www.webofscience.com/
BIOLOGIC CHOICES AFTER FIRST-LINE ANTI-TUMOUR NECROSIS FACTOR FAILURE IN NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (Conference Paper)
Richards, H., Baildam, E., McCann, L. J., Cleary, A. G., Beresford, M. W., & Pain, C. E. (2014). BIOLOGIC CHOICES AFTER FIRST-LINE ANTI-TUMOUR NECROSIS FACTOR FAILURE IN NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS. In RHEUMATOLOGY Vol. 53 (pp. 8). Retrieved from https://www.webofscience.com/
Factors Associated with Choice of First Biologic Among Children with Juvenile Idiopathic Arthritis: A Combined Analysis from 2 UK Paediatric Biologic Registers. (Journal article)
Davies, R., Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2014). Factors Associated with Choice of First Biologic Among Children with Juvenile Idiopathic Arthritis: A Combined Analysis from 2 UK Paediatric Biologic Registers.. ARTHRITIS & RHEUMATOLOGY, 66, S114-S115. Retrieved from https://www.webofscience.com/
Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling (Journal article)
Rice, G. I., Duany, Y. D. T., Jenkinson, E. M., Forte, G. M. A., Anderson, B. H., Ariaudo, G., . . . Crow, Y. J. (2014). Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. NATURE GENETICS, 46(5), 503-509. doi:10.1038/ng.2933DOI: 10.1038/ng.2933
IMPROVING CARE IN PAEDIATRIC RHEUMATIC DISEASES: THE SHARE PROJECT (Conference Paper)
Groot, N., Vastert, B., Wulffraat, N. M., & Beresford, M. W. (2014). IMPROVING CARE IN PAEDIATRIC RHEUMATIC DISEASES: THE SHARE PROJECT. In RHEUMATOLOGY Vol. 53 (pp. 22). Retrieved from https://www.webofscience.com/
IMPROVING CARE IN PAEDIATRIC RHEUMATOLOGIC DISEASES: THE SHARE PROJECT (Conference Paper)
Groot, N., Vastert, B., Wulffraat, N. M., & Beresford, M. W. (2014). IMPROVING CARE IN PAEDIATRIC RHEUMATOLOGIC DISEASES: THE SHARE PROJECT. In RHEUMATOLOGY Vol. 53 (pp. 12-13). Retrieved from https://www.webofscience.com/
INVESTIGATING BIOMARKERS OF DISEASE ACTIVITY IN JUVENILE-ONSET LUPUS NEPHRITIS (Conference Paper)
Smith, E. M. D., Watson, L., Jones, C., Pilkington, C. A., Marks, S. D., Tullus, K., & Beresford, M. W. (2014). INVESTIGATING BIOMARKERS OF DISEASE ACTIVITY IN JUVENILE-ONSET LUPUS NEPHRITIS. In RHEUMATOLOGY Vol. 53 (pp. 21). Retrieved from https://www.webofscience.com/
INVESTIGATING PHAGOCYTOSIS RECEPTORS IN SERUM FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHREMATOSUS PATIENTS (Conference Paper)
Burgess, S. L., Ballantine, L., Midgley, A., & Beresford, M. W. (2014). INVESTIGATING PHAGOCYTOSIS RECEPTORS IN SERUM FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHREMATOSUS PATIENTS. In RHEUMATOLOGY Vol. 53 (pp. 21). Retrieved from https://www.webofscience.com/
Methodology of clinical trials for rare diseases (Journal article)
Smith, C. T., Williamson, P. R., & Beresford, M. W. (2014). Methodology of clinical trials for rare diseases. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 28(2), 247-262. doi:10.1016/j.berh.2014.03.004DOI: 10.1016/j.berh.2014.03.004
Methodology of clinical trials for rare diseases (Journal article)
Tudur Smith, C., Williamson, P. R., & Beresford, M. W. (2014). Methodology of clinical trials for rare diseases. Best Practice and Research: Clinical Rheumatology, 28(2), 247-262. doi:10.1016/j.berh.2014.03.004DOI: 10.1016/j.berh.2014.03.004
Predictors of access to care in patients with juvenile systemic lupus erythematosus (Journal article)
Smith, E. M. D., Foster, H. E., Gray, W. K., Taylor-Robinson, D., & Beresford, M. W. (2014). Predictors of access to care in patients with juvenile systemic lupus erythematosus. BRITISH JOURNAL OF HOSPITAL MEDICINE, 75(2), 69. Retrieved from https://www.webofscience.com/
RELATIVE EXPRESSION OF KIDNEY-ASSOCIATED PROTEINS IN LUPUS NEPHRITIS: IDENTIFYING FUTURE URINARY BIOMARKER TARGETS FOR DISEASE MONITORING (Conference Paper)
Smith, E. M. D., Midgley, A., Watson, L., Jones, C., Pilkington, C., Marks, S. D., . . . Beresford, M. W. (2014). RELATIVE EXPRESSION OF KIDNEY-ASSOCIATED PROTEINS IN LUPUS NEPHRITIS: IDENTIFYING FUTURE URINARY BIOMARKER TARGETS FOR DISEASE MONITORING. In RHEUMATOLOGY Vol. 53 (pp. 183-184). Retrieved from https://www.webofscience.com/
Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register (Journal article)
Sutton, E., Watson, K. D., Isenberg, D. A., Rahman, A., Jayne, D., Gordon, C., . . . Bruce, I. N. (2014). Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register. ARTHRITIS & RHEUMATOLOGY, 66, S295. Retrieved from https://www.webofscience.com/
THE EFFICACY OF RITUXIMAB IN JUVENILE-ONSET SLE: A RETROSPECTIVE COHORT STUDY (Conference Paper)
Watson, L., Maynes, C., Pilkington, C., Marks, S., Beresford, M. W., & Tullus, K. (2014). THE EFFICACY OF RITUXIMAB IN JUVENILE-ONSET SLE: A RETROSPECTIVE COHORT STUDY. In RHEUMATOLOGY Vol. 53 (pp. 14). Retrieved from https://www.webofscience.com/
THE PREVALENCE AND INTERPRETATION OF ANTIPHOSPHOLIPID ANTIBODIES IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS (Conference Paper)
Saleem, M. S., Simpson, D. L., Roberts, C. J., Ramanan, A. V., & Beresford, M. W. (2014). THE PREVALENCE AND INTERPRETATION OF ANTIPHOSPHOLIPID ANTIBODIES IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS. In RHEUMATOLOGY Vol. 53 (pp. 20). Retrieved from https://www.webofscience.com/
TWO CASES OF JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS WITH UNCOMMON ASSOCIATIONS AND CHALLENGES IN THERAPY (Conference Paper)
Sampath, S., Cleary, A. G., Pain, C. E., Baildam, E., Beresford, M. W., & McCann, L. J. (2014). TWO CASES OF JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS WITH UNCOMMON ASSOCIATIONS AND CHALLENGES IN THERAPY. In RHEUMATOLOGY Vol. 53 (pp. 11). Retrieved from https://www.webofscience.com/
USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY (Conference Paper)
Kearsley-Fleet, L., Baildam, E., Beresford, M., Davies, R., Foster, H. E., Mowbray, K., . . . Hyrich, K. L. (2014). USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY. In RHEUMATOLOGY Vol. 53 (pp. 169-170). Retrieved from https://www.webofscience.com/
USE OF RITUXIMAB IN RHEUMATOID FACTOR NEGATIVE JUVENILE RHEUMATOID ARTHRITIS (Conference Paper)
Sampath, S., Baildam, E., Cleary, A. G., Pain, C. E., Beresford, M. W., & McCann, L. J. (2014). USE OF RITUXIMAB IN RHEUMATOID FACTOR NEGATIVE JUVENILE RHEUMATOID ARTHRITIS. In RHEUMATOLOGY Vol. 53 (pp. 11). Retrieved from https://www.webofscience.com/
2013
Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis (Journal article)
Mcerlane, F., Beresford, M. W., Baildam, E. M., Chieng, S. E. A., Davidson, J. E., Foster, H. E., . . . Hyrich, K. L. (2013). Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis. ANNALS OF THE RHEUMATIC DISEASES, 72(12), 1983-1988. doi:10.1136/annrheumdis-2012-202031DOI: 10.1136/annrheumdis-2012-202031
Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis (Journal article)
McErlane, F., Beresford, M. W., Baildam, E. M., Thomson, W., & Hyrich, K. L. (2013). Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis. RHEUMATOLOGY, 52(11), 1941-1951. doi:10.1093/rheumatology/ket150DOI: 10.1093/rheumatology/ket150
International Consensus for Provisions of Quality-Driven Care in Childhood-Onset Systemic Lupus Erythematosus (Journal article)
Hollander, M. C., Sage, J. M., Greenler, A. J., Pendl, J., Avcin, T., Espada, G., . . . Brunner, H. I. (2013). International Consensus for Provisions of Quality-Driven Care in Childhood-Onset Systemic Lupus Erythematosus. ARTHRITIS CARE & RESEARCH, 65(9), 1416-1423. doi:10.1002/acr.21998DOI: 10.1002/acr.21998
NIHR Medicines for Children Research Network: improving children's health through clinical research (Journal article)
Rose, A. C., Van't Hoff, W., Beresford, M. W., & Tansey, S. P. (2013). NIHR Medicines for Children Research Network: improving children's health through clinical research. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 6(5), 581-587. doi:10.1586/17512433.2013.831531DOI: 10.1586/17512433.2013.831531
Protein Kinase C Deficiency Causes Mendelian Systemic Lupus Erythematosus With B Cell-Defective Apoptosis and Hyperproliferation (Journal article)
Belot, A., Kasher, P. R., Trotter, E. W., Foray, A. -P., Debaud, A. -L., Rice, G. I., . . . Bonnefoy, N. (2013). Protein Kinase C Deficiency Causes Mendelian Systemic Lupus Erythematosus With B Cell-Defective Apoptosis and Hyperproliferation. ARTHRITIS AND RHEUMATISM, 65(8), 2161-2171. doi:10.1002/art.38008DOI: 10.1002/art.38008
How to use ... lupus anticoagulants (Journal article)
Sen, E. S., Beresford, M. W., Avcin, T., & Ramanan, A. V. (2013). How to use ... lupus anticoagulants. ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 98(2), 52-57. doi:10.1136/archdischild-2012-302321DOI: 10.1136/archdischild-2012-302321
Urine biomarkers in juvenile-onset SLE nephritis (Journal article)
Watson, L., & Beresford, M. W. (2013). Urine biomarkers in juvenile-onset SLE nephritis. PEDIATRIC NEPHROLOGY, 28(3), 363-374. doi:10.1007/s00467-012-2184-yDOI: 10.1007/s00467-012-2184-y
Urine biomarkers in juvenile-onset SLE nephritis. (Journal article)
Watson, L., & Beresford, M. (2013). Urine biomarkers in juvenile-onset SLE nephritis.. Pediatric Nephrology, 28(3), 363-374.
Smith, E. M. D., Foster, H. E., & Beresford, M. W. (2013). Adding to complexity: comorbidity in paediatric rheumatic disease. RHEUMATOLOGY, 52(1), 22-33. doi:10.1093/rheumatology/kes256DOI: 10.1093/rheumatology/kes256
Children and adolescents with SLE: not just little adults (Journal article)
Morgan, T. A., Watson, L., McCann, L. J., & Beresford, M. W. (2013). Children and adolescents with SLE: not just little adults. LUPUS, 22(12), 1309-1319. doi:10.1177/0961203313502863DOI: 10.1177/0961203313502863
MINIMAL DISEASE ACTIVITY IN A CLINICAL COHORT OF CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE CHILDHOOD ARTHRITIS PROSPECTIVE STUDY (Conference Paper)
McErlane, F., Beresford, M., Baildam, E., Chieng, S. E., Davidson, J., Foster, H. E., . . . Hyrich, K. (2013). MINIMAL DISEASE ACTIVITY IN A CLINICAL COHORT OF CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE CHILDHOOD ARTHRITIS PROSPECTIVE STUDY. In RHEUMATOLOGY Vol. 52 (pp. 119-120). Retrieved from https://www.webofscience.com/
Paediatric use of mycophenolate mofetil (Journal article)
Downing, H. J., Pirmohamed, M., Beresford, M. W., & Smyth, R. L. (2013). Paediatric use of mycophenolate mofetil. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 75(1), 45-59. doi:10.1111/j.1365-2125.2012.04305.xDOI: 10.1111/j.1365-2125.2012.04305.x
USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY (Conference Paper)
Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Davies, R., Foster, H. E., Mowbray, K., . . . Hyrich, K. L. (2013). USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY. In RHEUMATOLOGY Vol. 52 (pp. 118-119). Retrieved from https://www.webofscience.com/
2012
Introduction (Journal article)
Pilkington, C., Beresford, M. W., Foster, H., & Walsh, J. (2012). Introduction. RHEUMATOLOGY, 51, 1. doi:10.1093/rheumatology/ket117DOI: 10.1093/rheumatology/ket117
Increased Serum Concentration of Sphingosine-1-phosphate in Juvenile-onset Systemic Lupus Erythematosus (Journal article)
Watson, L., Tullus, K., Marks, S. D., Holt, R. C. L., Pilkington, C., & Beresford, M. W. (2012). Increased Serum Concentration of Sphingosine-1-phosphate in Juvenile-onset Systemic Lupus Erythematosus. JOURNAL OF CLINICAL IMMUNOLOGY, 32(5), 1019-1025. doi:10.1007/s10875-012-9710-3DOI: 10.1007/s10875-012-9710-3
Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort. (Journal article)
Watson, L., Leone, V., Pilkington, C., Tullus, K., Rangaraj, S., McDonagh, J. E., . . . Beresford, M. (2012). Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.. Arthritis and Rheumatism, 64(7), 2356-2365.
Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort (Journal article)
Watson, L., Leone, V., Pilkington, C., Tullus, K., Rangaraj, S., McDonagh, J. E., . . . Beresford, M. W. (2012). Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort. ARTHRITIS AND RHEUMATISM, 64(7), 2356-2365. doi:10.1002/art.34410DOI: 10.1002/art.34410
Standard 5: Selection, Measurement, and Reporting of Outcomes in Clinical Trials in Children (Journal article)
Sinha, I. P., Altman, D. G., Beresford, M. W., Boers, M., Clarke, M., Craig, J., . . . Smyth, R. L. (2012). Standard 5: Selection, Measurement, and Reporting of Outcomes in Clinical Trials in Children. PEDIATRICS, 129, S146-S152. doi:10.1542/peds.2012-0055HDOI: 10.1542/peds.2012-0055H
Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE (Journal article)
Midgley, A., Thorbinson, C., & Beresford, M. W. (2012). Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE. Rheumatology, 51(5), 824-832. doi:10.1093/rheumatology/ker400DOI: 10.1093/rheumatology/ker400
Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE (Journal article)
Midgley, A., Thorbinson, C., & Beresford, M. W. (2012). Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE. RHEUMATOLOGY, 51(5), 824-832. doi:10.1093/rheumatology/ker400DOI: 10.1093/rheumatology/ker400
Inactive Disease and Remission in Childhood-Onset Systemic Lupus Erythematosus (Journal article)
Mina, R., Klein-Gitelman, M. S., Ravelli, A., Beresford, M. W., Avcin, T., Espada, G., . . . Brunner, H. I. (2012). Inactive Disease and Remission in Childhood-Onset Systemic Lupus Erythematosus. ARTHRITIS CARE & RESEARCH, 64(5), 683-693. doi:10.1002/acr.21612DOI: 10.1002/acr.21612
Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus (Journal article)
Watson, L., Midgley, A., Pilkington, C., Tullus, K., Marks, S. D., Holt, R. C. L., . . . Beresford, M. W. (2012). Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus. LUPUS, 21(5), 496-501. doi:10.1177/0961203311431249DOI: 10.1177/0961203311431249
Henoch Schonlein Purpura - A 5-Year Review and Proposed Pathway (Journal article)
Watson, L., Richardson, A. R. W., Holt, R. C. L., Jones, C. A., & Beresford, M. W. (2012). Henoch Schonlein Purpura - A 5-Year Review and Proposed Pathway. PLOS ONE, 7(1). doi:10.1371/journal.pone.0029512DOI: 10.1371/journal.pone.0029512
A NOVEL ASSAY FOR DETECTING NITRATED NUCLEOSOMES: A POTENTIAL SURROGATE BIOMARKER FOR JUVENILE ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (Conference Paper)
Pericleous, C., Croca, S. C., Giles, I., Alber, K., Yong, H., Isenberg, D., . . . Ioannou, Y. (2012). A NOVEL ASSAY FOR DETECTING NITRATED NUCLEOSOMES: A POTENTIAL SURROGATE BIOMARKER FOR JUVENILE ONSET SYSTEMIC LUPUS ERYTHEMATOSUS. In RHEUMATOLOGY Vol. 51 (pp. 110). Retrieved from https://www.webofscience.com/
A novel method for investigating macrophage phagocytosis in juvenile systemic lupus erythematosus using the pH sensitive dye pHRodo (Conference Paper)
Ballantine, L., Harris, D., & Beresford, M. W. (2012). A novel method for investigating macrophage phagocytosis in juvenile systemic lupus erythematosus using the pH sensitive dye pHRodo. In IMMUNOLOGY Vol. 137 (pp. 571). Retrieved from https://www.webofscience.com/
DOES EXCLUSION OF THE ESR FROM JADAS AFFECT VALIDITY IN THE ROUTINE CLINICAL SETTING? (Conference Paper)
McErlane, F., Beresford, M. W., Baildam, E. M., Thomson, W., Hyrich, K., Chieng, A., . . . Wedderburn, L. (2012). DOES EXCLUSION OF THE ESR FROM JADAS AFFECT VALIDITY IN THE ROUTINE CLINICAL SETTING?. In RHEUMATOLOGY Vol. 51 (pp. 109). Retrieved from https://www.webofscience.com/
Henoch schonlein purpura--a 5-year review and proposed pathway (Journal article)
Watson, L., Richardson, A. R. W., Holt, R. C. L., Jones, C. A., & Beresford, M. (2012). Henoch schonlein purpura--a 5-year review and proposed pathway. PloS one, 7(1).
Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus (Journal article)
Watson, L., Tullus, K., Marks, S. D., Holt, R. C. L., Pilkington, C., & Beresford, M. W. (2012). Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus. J Clin Immunol, 32(5), 1019-1025.
Juvenile idiopathic arthritis: Symptoms and diagnosis. (Journal article)
Kelly, J., & Beresford, M. W. (2012). Juvenile idiopathic arthritis: Symptoms and diagnosis.. British Journal of School Nursing, 7(3), 117-120.
NOVEL URINARY BIOMARKERS OUTPERFORM STANDARD BIOMARKERS IN JUVENILE LUPUS NEPHRITIS: A PROSPECTIVE LONGITUDINAL VALIDATION STUDY (Conference Paper)
Watson, L., Tullus, K., Pilkington, C., Chesters, C., Marks, S. D., Newland, P., . . . Beresford, M. W. (2012). NOVEL URINARY BIOMARKERS OUTPERFORM STANDARD BIOMARKERS IN JUVENILE LUPUS NEPHRITIS: A PROSPECTIVE LONGITUDINAL VALIDATION STUDY. In RHEUMATOLOGY Vol. 51 (pp. 2). Retrieved from https://www.webofscience.com/
PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY (Conference Paper)
Smith, E., Gray, W., Taylor-Robinson, D., Foster, H. E., & Beresford, M. W. (2012). PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY. In RHEUMATOLOGY Vol. 51 (pp. 8-9). Retrieved from https://www.webofscience.com/
PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY (Conference Paper)
Smith, E., Gray, W., Taylor-Robinson, D., Foster, H. E., & Beresford, M. W. (2012). PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY. In RHEUMATOLOGY Vol. 51 (pp. 8-9). Retrieved from https://www.webofscience.com/
PREVALENCE AND SIGNIFICANCE OF THROMBOCYTOPENIA IN JUVENILE ONSET SLE AT PRESENTATION AND 1-YEAR FOLLOW-UP (Conference Paper)
Gohar, F., Watson, L., & Beresford, M. W. (2012). PREVALENCE AND SIGNIFICANCE OF THROMBOCYTOPENIA IN JUVENILE ONSET SLE AT PRESENTATION AND 1-YEAR FOLLOW-UP. In RHEUMATOLOGY Vol. 51 (pp. 9). Retrieved from https://www.webofscience.com/
PREVALENCE AND SIGNIFICANCE OF THROMBOCYTOPENIA IN JUVENILE ONSET SLE AT PRESENTATION AND 1-YEAR FOLLOW-UP (Conference Paper)
Gohar, F., Watson, L., & Beresford, M. W. (2012). PREVALENCE AND SIGNIFICANCE OF THROMBOCYTOPENIA IN JUVENILE ONSET SLE AT PRESENTATION AND 1-YEAR FOLLOW-UP. In RHEUMATOLOGY Vol. 51 (pp. 9). Retrieved from https://www.webofscience.com/
Standards for child health trial design, conduct and reporting: Standard 5: Selection, measurement and reporting of outcomes (Journal article)
Sinha, I. P., Altman, D., Beresford, M. W., Boers, M., Clarke, M., Craig, J., . . . Smyth, R. L. (2012). Standards for child health trial design, conduct and reporting: Standard 5: Selection, measurement and reporting of outcomes. Pediatrics, 129(Suppl), 146-152.
Stimulation of Juvenile systemic lupus erythematosus blood cells induces IL-17 production (Journal article)
Ballantine, L., Ong, J., Midgley, A., Watson, L., & Beresford, M. W. (2012). Stimulation of Juvenile systemic lupus erythematosus blood cells induces IL-17 production. IMMUNOLOGY, 137, 259. Retrieved from https://www.webofscience.com/
USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JIA: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY (Conference Paper)
Kearsley-Fleet, L., Baildam, E., Beresford, M., Davies, R., Foster, H. E., Mowbray, K., . . . Hyrich, K. L. (2012). USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JIA: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY. In RHEUMATOLOGY Vol. 51 (pp. 8). Retrieved from https://www.webofscience.com/
USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JIA: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY (Conference Paper)
Kearsley-Fleet, L., Baildam, E., Beresford, M., Davies, R., Foster, H. E., Mowbray, K., . . . Hyrich, K. L. (2012). USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JIA: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY. In RHEUMATOLOGY Vol. 51 (pp. 8). Retrieved from https://www.webofscience.com/
Urinary Monocyte Chemoattractant protein 1 and Alpha-1-acid glycoprotein as biomarkers of renal disease activity in Juvenile-onset Systemic Lupus Erythematosus (Journal article)
Watson, L., Midgley, A., Pilkington, C., Tullus, K., Holt, R. L., Marks, S., . . . Beresford, M. W. (2012). Urinary Monocyte Chemoattractant protein 1 and Alpha-1-acid glycoprotein as biomarkers of renal disease activity in Juvenile-onset Systemic Lupus Erythematosus. Lupus, 21, 496-501.
VALIDATION OF JADAS IN ALL SUBTYPES OF JUVENILE IDIOPATHIC ARTHRITIS IN A CLINICAL SETTING (Conference Paper)
McErlane, F., Beresford, M. W., Baildam, E. M., Thomson, W., Hyrich, K., Chieng, A., . . . Wedderburn, L. (2012). VALIDATION OF JADAS IN ALL SUBTYPES OF JUVENILE IDIOPATHIC ARTHRITIS IN A CLINICAL SETTING. In RHEUMATOLOGY Vol. 51 (pp. 27). Retrieved from https://www.webofscience.com/
WHY IS IT IMPORTANT TO KNOW ABOUT LUPUS IN CHILDREN? (Conference Paper)
Beresford, M. W. (2012). WHY IS IT IMPORTANT TO KNOW ABOUT LUPUS IN CHILDREN?. In RHEUMATOLOGY Vol. 51 (pp. 13). Retrieved from https://www.webofscience.com/
2011
Diagnosis and management of juvenile-onset SLE (Journal article)
Watson, L., Gohar, F., & Beresford, M. W. (2011). Diagnosis and management of juvenile-onset SLE. Paediatrics and Child Health, 21(12), 539-545. doi:10.1016/j.paed.2011.06.005DOI: 10.1016/j.paed.2011.06.005
Needle-free and microneedle drug delivery in children: A case for disease-modifying antirheumatic drugs (DMARDs) (Journal article)
Shah, U. U., Roberts, M., Gul, M. O., Tuleu, C., & Beresford, M. W. (2011). Needle-free and microneedle drug delivery in children: A case for disease-modifying antirheumatic drugs (DMARDs). INTERNATIONAL JOURNAL OF PHARMACEUTICS, 416(1), 1-11. doi:10.1016/j.ijpharm.2011.07.002DOI: 10.1016/j.ijpharm.2011.07.002
Preliminary Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus (Journal article)
Brunner, H. I., Mina, R., Pilkington, C., Beresford, M. W., Reiff, A., Levy, D. M., . . . Giannini, E. H. (2011). Preliminary Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus. ARTHRITIS CARE & RESEARCH, 63(9), 1213-1223. doi:10.1002/acr.20507DOI: 10.1002/acr.20507
Shilling, V., Williamson, P. R., Hickey, H., Sowden, E., Beresford, M. W., Smyth, R. L., & Young, B. (2011). Communication about Children's Clinical Trials as Observed and Experienced: Qualitative Study of Parents and Practitioners. PLOS ONE, 6(7). doi:10.1371/journal.pone.0021604DOI: 10.1371/journal.pone.0021604
Juvenile Idiopathic Arthritis New Insights into Classification, Measures of Outcome, and Pharmacotherapy (Journal article)
Beresford, M. W. (2011). Juvenile Idiopathic Arthritis New Insights into Classification, Measures of Outcome, and Pharmacotherapy. PEDIATRIC DRUGS, 13(3), 161-173. doi:10.2165/11588140-000000000-00000DOI: 10.2165/11588140-000000000-00000
Cellular localization of nuclear antigen during neutrophil apoptosis: mechanism for autoantigen exposure? (Journal article)
Midgley, A., & Beresford, M. W. (2011). Cellular localization of nuclear antigen during neutrophil apoptosis: mechanism for autoantigen exposure?. LUPUS, 20(6), 641-646. doi:10.1177/0961203310392421DOI: 10.1177/0961203310392421
Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature (Journal article)
Briggs, T. A., Rice, G. I., Daly, S., Urquhart, J., Gornall, H., Bader-Meunier, B., . . . Crow, Y. J. (2011). Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. NATURE GENETICS, 43(2), 127-U71. doi:10.1038/ng.748DOI: 10.1038/ng.748
Achieving Consensus on Quality Indicators for Pediatric Systemic Lupus Erythematosus (Conference Paper)
Pendl, J. D., Hollander, M. C., Nelson, S. L., Morgan, X., Ruperto, N., Beresford, M. W., . . . Brunner, H. (2011). Achieving Consensus on Quality Indicators for Pediatric Systemic Lupus Erythematosus. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S236-S237). Retrieved from https://www.webofscience.com/
Autoantibody Testing for Children on Biologic Therapies for Rheumatological Conditions: Results of Audit (Conference Paper)
Duncan, J., Heath, J., Baildam, E. M., Cleary, G., Beresford, M. W., & McCann, L. J. (2011). Autoantibody Testing for Children on Biologic Therapies for Rheumatological Conditions: Results of Audit. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S791). Retrieved from https://www.webofscience.com/
Communication about children's clinical trials as observed and experienced: qualitative study of parents and practitioners (Journal article)
Shilling, V., Williamson, P. R., Hickey, H., Sowden, E., Beresford, M. W., Smyth, R. L., & Young, B. (2011). Communication about children's clinical trials as observed and experienced: qualitative study of parents and practitioners. PLoS One, 6(7), e21604.
Differential expression of factors involved in the intrinsic and extrinsic apoptotic pathways in Juvenile Systemic Lupus Erythematosus: The role of caspases. (Journal article)
Midgley, A. M., Mayer, K., Edwards, S. W., & Beresford, M. W. (2011). Differential expression of factors involved in the intrinsic and extrinsic apoptotic pathways in Juvenile Systemic Lupus Erythematosus: The role of caspases.. Lupus, 20(1), 71.
Differential expression of factors involved in the intrinsic and extrinsic apoptotic pathways in juvenile systemic lupus erythematosus (Journal article)
Midgley, A., Mayer, K., Edwards, S. W., & Beresford, M. W. (2011). Differential expression of factors involved in the intrinsic and extrinsic apoptotic pathways in juvenile systemic lupus erythematosus. LUPUS, 20(1), 71-79. doi:10.1177/0961203310382128DOI: 10.1177/0961203310382128
International consensus for a definition of disease flare in lupus. (Journal article)
Ruperto, N., Hanrahan, L. M., Alarcón, G. S., Belmont, H. M., Brey, R. L., Brunetta, P., . . . al., E. (2011). International consensus for a definition of disease flare in lupus.. Lupus, 13(3), 453-462.
Investigating children's beliefs about Juvenile Arthritis: A Study Using Cognitive Interviewing. (Conference Paper)
Ghio, D., Thomson, W., Baildam, E. M., Hyrich, K., Beresford, M. W., Lydon, C., . . . Cordingley, L. (2011). Investigating children's beliefs about Juvenile Arthritis: A Study Using Cognitive Interviewing.. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S108-S109). Retrieved from https://www.webofscience.com/
Paediatric Connective Tissue Disorders (Chapter)
Wedderburn, L. R., Pilkington, C. A., & Beresford, M. W. (2011). Paediatric Connective Tissue Disorders. In M. Hochberg, A. J. Silman, J. S. Smolen, M. E. Weinblatt, & M. H. Weisman (Eds.), Rheumatology, 5th Edition (pp. 1035-1043). PA, USA: Elsevier,.
Th17 associated proteins in Juvenile systemic lupus erythematosus (Conference Paper)
Ballantine, L., Midgley, A., Watson, L., & Beresford, M. (2011). Th17 associated proteins in Juvenile systemic lupus erythematosus. In IMMUNOLOGY Vol. 135 (pp. 147). Retrieved from https://www.webofscience.com/
2010
Comment on: Developing standards of care for patients with juvenile idiopathic arthritis (Journal article)
Beresford, M. W., Cleary, A. G., Foster, H. E., Hutchinson, E., Baildam, E. M., & Davies, K. (2010). Comment on: Developing standards of care for patients with juvenile idiopathic arthritis. RHEUMATOLOGY, 49(11), 2227-2229. doi:10.1093/rheumatology/keq215DOI: 10.1093/rheumatology/keq215
A randomized comparative trial of generalized vs targeted physiotherapy in the management of childhood hypermobility (Journal article)
Kemp, S., Roberts, I., Gamble, C., Wilkinson, S., Davidson, J. E., Baildam, E. M., . . . Beresford, M. W. (2010). A randomized comparative trial of generalized vs targeted physiotherapy in the management of childhood hypermobility. RHEUMATOLOGY, 49(2), 315-325. doi:10.1093/rheumatology/kep362DOI: 10.1093/rheumatology/kep362
A retrospective clinical analysis of pharmacological modalities used for symptomatic relief of Raynaud's phenomenon in children treated in a UK paediatric rheumatology centre (Journal article)
Gargh, K., Baildam, E. M., Cleary, G. A., Beresford, M. W., & McCann, L. J. (2010). A retrospective clinical analysis of pharmacological modalities used for symptomatic relief of Raynaud's phenomenon in children treated in a UK paediatric rheumatology centre. RHEUMATOLOGY, 49(1), 193-194. doi:10.1093/rheumatology/kep309DOI: 10.1093/rheumatology/kep309
DIFFERENTIAL EXPRESSION OF FACTORS INVOLVED IN THE EXTRINSIC APOPTOTIC PATHWAY IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS (Conference Paper)
Midgley, A. J., & Beresford, M. W. (2010). DIFFERENTIAL EXPRESSION OF FACTORS INVOLVED IN THE EXTRINSIC APOPTOTIC PATHWAY IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS. In RHEUMATOLOGY Vol. 49 (pp. I43-I44). Retrieved from https://www.webofscience.com/
Disease modifying immunosuppressant drugs for juvenile-onset systemic lupus erythematosus. Cochrane Database of Systematic Reviews (Journal article)
Craig, J. V., Pain, C. E., & Beresford, M. W. (2010). Disease modifying immunosuppressant drugs for juvenile-onset systemic lupus erythematosus. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews, Issue.
2009
New advances in the management of juvenile idiopathic arthritis-1: Non-biological therapy (Journal article)
Beresford, M. W., & Baildam, E. M. (2009). New advances in the management of juvenile idiopathic arthritis-1: Non-biological therapy. ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 94(5), 144-150. doi:10.1136/adc.2008.144576DOI: 10.1136/adc.2008.144576
New advances in the management of juvenile idiopathic arthritis-2: The era of biologicals (Journal article)
Beresford, M. W., & Baildam, E. M. (2009). New advances in the management of juvenile idiopathic arthritis-2: The era of biologicals. ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 94(5), 151-156. doi:10.1136/adc.2009.170860DOI: 10.1136/adc.2009.170860
The Role of Neutrophil Apoptosis in Juvenile-Onset Systemic Lupus Erythematosus (Journal article)
Midgley, A., McLaren, Z., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2009). The Role of Neutrophil Apoptosis in Juvenile-Onset Systemic Lupus Erythematosus. ARTHRITIS AND RHEUMATISM, 60(8), 2390-2401. doi:10.1002/art.24634DOI: 10.1002/art.24634
"To find the right answers, you need to ask the right questions." Consumer involvement in setting our research agenda (Journal article)
Hill, H., Kelly, J., Kemp, S., Baildam, E., Cleary, A. G., McCann, L., & Beresford, M. W. (2009). "To find the right answers, you need to ask the right questions." Consumer involvement in setting our research agenda. Rheumatology, Pendin, Pending.
DELAY TO DIAGNOSIS IN JUVENILE SLE (JSLE) PATIENTS: PRELIMINARY DATA FROM THE UK JSLE COHORT STUDY (Journal article)
Pain, C., Gardner-Medwin, J., McDonagh, J., Pilkington, C., Satyapal, R., Tizard, J., . . . Beresford, M. W. (2009). DELAY TO DIAGNOSIS IN JUVENILE SLE (JSLE) PATIENTS: PRELIMINARY DATA FROM THE UK JSLE COHORT STUDY. RHEUMATOLOGY, 48, I46. Retrieved from https://www.webofscience.com/
Decreased expression of proteins that inhibit apoptosis in patients with JSLE compared to controls. (Journal article)
Midgley, A. J., & Beresford, M. W. (2009). Decreased expression of proteins that inhibit apoptosis in patients with JSLE compared to controls.. Rheumatology (accepted for BSR 2009), Pendin, Pending.
IMBALANCE OF PRO AND ANTI APOPTOTIC FACTORS IN PATIENTS WITH JSLE COMPARED TO CONTROLS (Conference Paper)
Midgley, A. J., & Beresford, M. W. (2009). IMBALANCE OF PRO AND ANTI APOPTOTIC FACTORS IN PATIENTS WITH JSLE COMPARED TO CONTROLS. In RHEUMATOLOGY Vol. 48 (pp. I31-I32). Retrieved from https://www.webofscience.com/
INCREASED CD80 AND CD86 IN THE SERUM OF PATIENTS WITH JSLE COMPARED TO CONTROLS (Conference Paper)
Midgley, A. J., & Beresford, M. W. (2009). INCREASED CD80 AND CD86 IN THE SERUM OF PATIENTS WITH JSLE COMPARED TO CONTROLS. In RHEUMATOLOGY Vol. 48 (pp. I34). Retrieved from https://www.webofscience.com/
Increased CD80 and CD86 in the serum of patients with JSLE compared to controls (Journal article)
Midgley, A., & Beresford, M. W. (2009). Increased CD80 and CD86 in the serum of patients with JSLE compared to controls. Rheumatology (accepted for BSR 2009), Pendin, Pending.
2008
Arthropathy in paediatric inflammatory bowel disease: a cross-sectional observational study (Journal article)
McErlane, F., Gillon, C., Irvine, T., Davidson, J. E., Casson, D., Dalzell, A. M., & Beresford, M. W. (2008). Arthropathy in paediatric inflammatory bowel disease: a cross-sectional observational study. RHEUMATOLOGY, 47(8), 1251-1252. doi:10.1093/rheumatology/ken217DOI: 10.1093/rheumatology/ken217
Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis (Journal article)
Thornton, J., Lunt, M., Ashcroft, D. M., Baildam, E., Foster, H., Davidson, J., . . . Elliott, R. A. (2008). Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis. RHEUMATOLOGY, 47(7), 985-990. doi:10.1093/rheumatology/ken039DOI: 10.1093/rheumatology/ken039
Improving the evidence base for treatment of juvenile idiopathic arthritis: the challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group (Journal article)
Thornton, J., Beresford, M. W., & Clayton, P. (2008). Improving the evidence base for treatment of juvenile idiopathic arthritis: the challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group. RHEUMATOLOGY, 47(5), 563-566. doi:10.1093/rheumatology/ken055DOI: 10.1093/rheumatology/ken055
A new new paradigm for musculoskeletal clinical trials in the UK: the Arthritis Research Campaign (arc) Clinical Studies Groups Initiative (Journal article)
Silman, A. (2008). A new new paradigm for musculoskeletal clinical trials in the UK: the Arthritis Research Campaign (arc) Clinical Studies Groups Initiative. Rheumatology.
Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis (Journal article)
Thornton, J., Lunt, M., Ashcroft, D. M., Baildam, E., Foster, H., Davidson, J., . . . Elliott, R. A. (2008). Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis. Rheumatology, Advanced publication 160408.
Increased neutrophil apoptosis may be associated with decreased levels of IL-6, GM-CSF and TNF-alpha concentrations in JSLE serum compared to controls (Journal article)
Midgley, A. J., McLaren, Z., Moots, R. J., Edwards, S. E., & Beresford, M. W. (2008). Increased neutrophil apoptosis may be associated with decreased levels of IL-6, GM-CSF and TNF-alpha concentrations in JSLE serum compared to controls. 3rd International Conference on Cytokine Medicine., *(*), *.
Inducing apoptosis: Increased TRAIL and FasL concentrations in JSLE serum compared to controls (Journal article)
Midgley, A. J., McLaren, Z. L., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2008). Inducing apoptosis: Increased TRAIL and FasL concentrations in JSLE serum compared to controls. Lupus, 17(5), suppl:495.
Modulation of the immune inhibitory pathway: Increased expression of TLR's in JSLE lymphocytes correlates with decreased FoxP3 expression (Journal article)
Midgley, A. J., & Beresford, M. W. (2008). Modulation of the immune inhibitory pathway: Increased expression of TLR's in JSLE lymphocytes correlates with decreased FoxP3 expression. Immunology, 125, (suppl 1):OP173.
Modulation of the immune inhibitory pathway: increased expression of TLR's in JSLE lymphocytes correlates with decreased FoxP3 expression (Conference Paper)
Midgley, A., Motaal, A., & Beresford, M. (2008). Modulation of the immune inhibitory pathway: increased expression of TLR's in JSLE lymphocytes correlates with decreased FoxP3 expression. In IMMUNOLOGY Vol. 125 (pp. 129). Retrieved from https://www.webofscience.com/
Peripheral T-Cell lymphoma in a five year old (Journal article)
Beresford, M. W., Wilkins, S., Ashworth, M., Davidson, J. E., McDowell, H., & Cleary, A. G. (2008). Peripheral T-Cell lymphoma in a five year old. PEDIATRIC BLOOD & CANCER, 50(1), 145-147. doi:10.1002/pbc.21055DOI: 10.1002/pbc.21055
Role of Neutrophil Apoptosis in Juvenile-onset SLE (Journal article)
McLaren, Z. L., Midgley, A. J., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2008). Role of Neutrophil Apoptosis in Juvenile-onset SLE. Rheumatology, 47, (suppl 2):ii94(320).
Steroid use in the management of acute juvenile systemic lupus erythematosus - A National Survey (Journal article)
McLaren, Z. L., Beresford, M. W., & on, B. O. U. J. S. G. (2008). Steroid use in the management of acute juvenile systemic lupus erythematosus - A National Survey. Rheumatology, 47, (suppl 2):ii27(89).
Steroid use in the management of acute juvenile systemic lupus erythematosus - A national survey (Conference Paper)
McLaren, Z. L., & Beresford, M. W. (2008). Steroid use in the management of acute juvenile systemic lupus erythematosus - A national survey. In RHEUMATOLOGY Vol. 47 (pp. II27). Retrieved from https://www.webofscience.com/
The Role of Neutrophil Apoptosis in Juvenile-onset Systemic Lupus Erythematosus (Journal article)
Midgley, A., McLaren, Z., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2008). The Role of Neutrophil Apoptosis in Juvenile-onset Systemic Lupus Erythematosus. ACR Pediatric Rheumatology Symposium, Keystone 2008, Awaite, Abstract 124.
The addition of granulocyte macrophage colony stimulating factor (GM-CSF) to Juvenile systemic lupus erythematusos serum can reduce abnormal neutrophil apoptosis (Journal article)
Midgley, A. J., McLaren, Z. L., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2008). The addition of granulocyte macrophage colony stimulating factor (GM-CSF) to Juvenile systemic lupus erythematusos serum can reduce abnormal neutrophil apoptosis. Pediatric Rheumatology, 6(Supp, P232.
The role of neutrophil apoptosis in juvenile systemic lupus erythematosus (Conference Paper)
McLaren, Z. L., Midgley, A., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2008). The role of neutrophil apoptosis in juvenile systemic lupus erythematosus. In RHEUMATOLOGY Vol. 47 (pp. II94). Retrieved from https://www.webofscience.com/
UK Paediatric rheumatology clinical trials network (Journal article)
Beresford, M., Balidam, E. M., Brogan, P. A., Foster, H. E., Ramanan, A. V., Rooney, M. E., . . . Woo, P. (2008). UK Paediatric rheumatology clinical trials network. Pediatric Rheumatology, 6(Supp, P150.
2007
Acrimonious acronyms: CRMO, SAPHO and a sore shin (vol 122, pg 252, 2007) (Journal article)
Beresford, M. W., Deutschmann, A., & Sullivan, K. E. (2007). Acrimonious acronyms: CRMO, SAPHO and a sore shin (vol 122, pg 252, 2007). CLINICAL IMMUNOLOGY, 124(3), 353. doi:10.1016/j.clim.2006.11.011DOI: 10.1016/j.clim.2006.11.011
ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency (Journal article)
Olsen, R. K. J., Olpin, S. E., Andresen, B. S., Miedzybrodzka, Z. H., Pourfarzam, M., Merinero, B., . . . Morris, A. A. M. (2007). ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. BRAIN, 130, 2045-2054. doi:10.1093/brain/awm135DOI: 10.1093/brain/awm135
Neonatal lupus syndrome (Journal article)
Pain, C., & Beresford, M. W. (2007). Neonatal lupus syndrome. Paediatrics and Child Health, 17(6), 223-227. doi:10.1016/j.paed.2007.03.002DOI: 10.1016/j.paed.2007.03.002
Acrimonious acronyms: CRMO, SAPHO and a sore shin (Journal article)
Beresford, M. W., Deautschmann, A., & Sullivan, K. E. (2007). Acrimonious acronyms: CRMO, SAPHO and a sore shin. CLINICAL IMMUNOLOGY, 122(3), 252-254. doi:10.1016/j.clim.2006.11.006DOI: 10.1016/j.clim.2006.11.006
Development of a national multi-centre, multi-disciplinary collaborative registry & repository of patients with juvenile-onset SLE (Journal article)
Beresford, M. W. (2007). Development of a national multi-centre, multi-disciplinary collaborative registry & repository of patients with juvenile-onset SLE. Lupus, 16 (su, 49.
Juvenile-onset Lupus (Chapter)
Beresford, M. W. (2007). Juvenile-onset Lupus. In Y. Norton (Ed.), Lupus: GP Guide to Diagnosis (pp. Awaited). London: Lupus UK.
2006
So doctor, what exactly is wrong with my muscles? Glutaric aciduria type II presenting in a teenager (Journal article)
Beresford, M. W., Pourfarzam, M., & Davidson, J. E. (2006). So doctor, what exactly is wrong with my muscles? Glutaric aciduria type II presenting in a teenager. NEUROMUSCULAR DISORDERS, 16(9-10), 613. doi:10.1016/j.nmd.2006.07.003DOI: 10.1016/j.nmd.2006.07.003
Adolescent development and SLE (Journal article)
Beresford, M. W., & Davidson, J. E. (2006). Adolescent development and SLE. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 20(2), 353-368. doi:10.1016/j.berh.2005.11.003DOI: 10.1016/j.berh.2005.11.003
So doctor, what exactly is wrong with my muscles? Glutaric aciduria type II presenting in a teenager (Journal article)
Beresford, M. W., Pourfarzam, M., Turnbull, D. M., & Davidson, J. E. (2006). So doctor, what exactly is wrong with my muscles? Glutaric aciduria type II presenting in a teenager. NEUROMUSCULAR DISORDERS, 16(4), 269-273. doi:10.1016/j.nmd.2006.01.001DOI: 10.1016/j.nmd.2006.01.001
Acute life threatening events among infants on home oxygen (Journal article)
Harrison, G., Beresford, M. W., & Shaw, N. (2006). Acute life threatening events among infants on home oxygen. Paediatric Nursing, 18(2), 27-29.
2005
Does sustained lung inflation at resuscitation reduce lung injury in the preterm infant? (Journal article)
Harling, A. E., Beresford, M. W., Vince, G. S., Bates, M., & Yoxall, C. W. (2005). Does sustained lung inflation at resuscitation reduce lung injury in the preterm infant?. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 90(5), F406-F410. doi:10.1136/adc.2004.059303DOI: 10.1136/adc.2004.059303
Does the use of 50% oxygen at birth in preterm infants reduce lung injury? (Journal article)
Harling, A. E., Beresford, M. W., Vince, G. S., Bates, M., & Yoxall, C. W. (2005). Does the use of 50% oxygen at birth in preterm infants reduce lung injury?. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 90(5), F401-F405. doi:10.1136/adc.2004.059287DOI: 10.1136/adc.2004.059287
Arthropathy in children with inflammatory bowel disease: a cross-sectional observational study (Journal article)
Erlane, F., Gillon, C., Irvine, T., Beresford, M. W., & Davidson, J. (2005). Arthropathy in children with inflammatory bowel disease: a cross-sectional observational study. Arch Dis Child, 90 (s2, A52.
Cardiopulmonary involvement in juvenile systemic lupus erythematosus (Journal article)
Beresford, M. W., Cleary, A. G., Sills, J. A., Couriel, J., & Davidson, J. E. (2005). Cardiopulmonary involvement in juvenile systemic lupus erythematosus. Lupus, 14(1), 152-158.
Clinical presentation and subsequent manifestations of juvenile-onset SLE in the UK (Journal article)
Beresford, M. W., Hernandez, T., McDonagh, J., Ryder, C. A. J., & Davidson, J. E. (2005). Clinical presentation and subsequent manifestations of juvenile-onset SLE in the UK. Lupus, 14, 259.
Delayed diagnosis: JIA in children with learning difficulties (Journal article)
Beresford, M. W., Cleary, G., Sills, J. A., & Davidson, J. E. (2005). Delayed diagnosis: JIA in children with learning difficulties. RHEUMATOLOGY, 44, I121. Retrieved from https://www.webofscience.com/
Evaluation of a limping child (Journal article)
Beresford, M. W., & Cleary, A. G. (2005). Evaluation of a limping child. Current Paediatrics, 15, 15-22.
Paediatric blood monitoring on methotrexate: How often are results abnormal? (Journal article)
Kelly, J., Cleary, A. G., Davidson, J. E., Sills, J., & Beresford, M. W. (2005). Paediatric blood monitoring on methotrexate: How often are results abnormal?. Clin Exp Rheumatol, 23 sup, S75.
Peripheral T-cell lymphoma: Important differential diagnosis of panniculitis in 5 year old (Journal article)
Beresford, M. W., Ashworth, M., McErlane, F., Davidson, J. E., & Cleary, A. G. (2005). Peripheral T-cell lymphoma: Important differential diagnosis of panniculitis in 5 year old. Clin Exp Rheumatol, 23 sup, S76.
Twelve month prospective study of oxygen saturation measurements among term and preterm infants (Journal article)
Beresford, M. W., Parry, H., & Shaw, N. J. (2005). Twelve month prospective study of oxygen saturation measurements among term and preterm infants. J Perinatol, 25, 30-32.
2004
Association of glutathione-S-transferase-P1 (GSTP1) polymorphism 105 Ile>val with chronic lung disease in preterm infants. (Journal article)
Cooke, R. W., Drury, J. A., Beresford, M. W., & Shaw, N. J. (2004). Association of glutathione-S-transferase-P1 (GSTP1) polymorphism 105 Ile>val with chronic lung disease in preterm infants.. Journal of perinatology : official journal of the California Perinatal Association, 24(12), 800. doi:10.1038/sj.jp.7211145DOI: 10.1038/sj.jp.7211145
Pamidronate in the treatment of childhood SAPHO syndrome (Journal article)
Kerrison, C., Davidson, J. E., Cleary, A. G., & Beresford, M. W. (2004). Pamidronate in the treatment of childhood SAPHO syndrome. RHEUMATOLOGY, 43(10), 1246-1251. doi:10.1093/rheumatology/keh295DOI: 10.1093/rheumatology/keh295
2003
Bronchoalveolar lavage surfactant protein A, B, and D concentrations in preterm infants ventilated for respiratory distress syndrome receiving natural and synthetic surfactants (Journal article)
Beresford, M. W., & Shaw, N. J. (2003). Bronchoalveolar lavage surfactant protein A, B, and D concentrations in preterm infants ventilated for respiratory distress syndrome receiving natural and synthetic surfactants. PEDIATRIC RESEARCH, 53(4), 663-670. doi:10.1203/01.PDR.0000054653.89527.F8DOI: 10.1203/01.PDR.0000054653.89527.F8
2002
Detectable IL-8 and IL-10 in Bronchoalveolar Lavage Fluid from Preterm Infants Ventilated for Respiratory Distress Syndrome (Journal article)
Beresford, M. W., & Shaw, N. J. (2002). Detectable IL-8 and IL-10 in Bronchoalveolar Lavage Fluid from Preterm Infants Ventilated for Respiratory Distress Syndrome. Pediatric Research, 52(6), 973-978. doi:10.1203/00006450-200212000-00025DOI: 10.1203/00006450-200212000-00025
Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome (Journal article)
Beresford, M. W., & Shaw, N. J. (2002). Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome. PEDIATRIC RESEARCH, 52(6), 973-978. doi:10.1203/01.PDR.0000036626.67304.65DOI: 10.1203/01.PDR.0000036626.67304.65
Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease (Journal article)
Beresford, M. W., Primhak, R., Subhedar, N. V., & Shaw, N. J. (2002). Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 87(1), F62-F63. doi:10.1136/fn.87.1.F62DOI: 10.1136/fn.87.1.F62
Randomised, double blind, placebo controlled trail of inhaled fluticasone for chronic lung disease of prematurity. (Journal article)
Beresford, M. W., Primak, R., Subhedar, N. S., & Shaw, N. J. (2002). Randomised, double blind, placebo controlled trail of inhaled fluticasone for chronic lung disease of prematurity.. Arch Dis Child Fetal Neonatal Ed, 87(1), F62-F63.
2000
Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort (Journal article)
Clark, S. J., Beresford, M. W., Subhedar, N. V., & Shaw, N. J. (2000). Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort. ARCHIVES OF DISEASE IN CHILDHOOD, 83(4), 313-316. doi:10.1136/adc.83.4.313DOI: 10.1136/adc.83.4.313
Outcome of congenital diaphragmatic hernia (Journal article)
Beresford, M. W., & Shaw, N. J. (2000). Outcome of congenital diaphragmatic hernia. PEDIATRIC PULMONOLOGY, 30(3), 249-256. Retrieved from https://www.webofscience.com/
Pumactant and poractant alfa in respiratory distress syndrome - Reply (Journal article)
Ainsworth, S. B., Beresford, M. W., Milligan, D. W. A., Shaw, N. J., & Mathews, J. N. S. (2000). Pumactant and poractant alfa in respiratory distress syndrome - Reply. LANCET, 356(9231), 766. doi:10.1016/S0140-6736(05)73664-3DOI: 10.1016/S0140-6736(05)73664-3
Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial (Journal article)
Ainsworth, S. B., Beresford, M. W., Milligan, D. W. A., Shaw, N. J., Matthews, J. N. S., Fenton, A. C., & Platt, M. P. W. (2000). Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial. LANCET, 355(9213), 1387-1392. doi:10.1016/S0140-6736(00)02136-XDOI: 10.1016/S0140-6736(00)02136-X
A Review of Outcome of Babies with Congenital Diaphragmatic Hernia (Journal article)
Beresford, M. W., & Shaw, N. J. (2000). A Review of Outcome of Babies with Congenital Diaphragmatic Hernia. Pediatr Pulmonol, 30(3), 249-256.
Poractant alfa and pumactant for treatment of respiratory distress syndrome in neonates born at 25 to 29 weeks¿ gestation: a randomised trial (Journal article)
Ainsworth, S., Beresford, M. W., Milligan, D. W. A., Shaw, N. J., Matthews, J. N. S., Fenton, A. C., & Ward Platt, M. P. (2000). Poractant alfa and pumactant for treatment of respiratory distress syndrome in neonates born at 25 to 29 weeks¿ gestation: a randomised trial. Lancet, 355(9213), 1387-1392.
Pumactant and poractant alfa in respiratory distress syndrome. Correspondence (Journal article)
Ainsworth, S., Beresford, M. W., Milligan, D. W. A., Shaw, N. J., & Matthews, J. N. S. (2000). Pumactant and poractant alfa in respiratory distress syndrome. Correspondence. Lancet, 356, 765-766.
Randomised controlled trial of patient triggered and conventional fast rate ventilation in neonatal respiratory distress syndrome (Journal article)
Beresford, M. W., Shaw, N. J., & Manning, D. (2000). Randomised controlled trial of patient triggered and conventional fast rate ventilation in neonatal respiratory distress syndrome. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 82(1), F14-F18. doi:10.1136/fn.82.1.F14DOI: 10.1136/fn.82.1.F14
